{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer", "natural products", "phytochemical", "phytomedicine"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31683894", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "02"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "01"}], "Language": ["eng"], "ELocationID": ["679", "10.3390/biom9110679"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "9", "Issue": "11", "PubDate": {"Year": "2019", "Month": "Nov", "Day": "01"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Natural Products and Synthetic Analogs as a Source of Antitumor Drugs.", "Abstract": {"AbstractText": ["Cancer is a heterogeneous disease and one of the major issues of health concern, especially for the public health system globally. Nature is a source of anticancer drugs with abundant pool of diverse chemicals and pharmacologically active compounds. In recent decade, some natural products and synthetic analogs have been investigated for the cancer treatment. This article presents the utilization of natural products as a source of antitumor drugs."]}, "AuthorList": [{"Identifier": ["0000-0002-7301-8151"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol 61615-585, Iran. javad.sharifirad@gmail.com."}], "LastName": "Sharifi-Rad", "ForeName": "Javad", "Initials": "J"}, {"Identifier": ["0000-0003-0195-3383"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Program of Biomolecular Sciences, Institute of Natural and Applied Sciences, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey. ademozleyen@gmail.com."}], "LastName": "Ozleyen", "ForeName": "Adem", "Initials": "A"}, {"Identifier": ["0000-0002-1740-4867"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Biology and Genetics, Faculty of Arts and Science, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey. tumertb@gmail.com."}], "LastName": "Boyunegmez Tumer", "ForeName": "Tugba", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Microbiology, Biotechnology and Nanotechnology Laboratory, Department of Microbiology, Edo University, Iyamho, Edo State 300271, Nigeria. adetunji.charles@edouniversity.edu.ng."}], "LastName": "Oluwaseun Adetunji", "ForeName": "Charles", "Initials": "C"}, {"Identifier": ["0000-0002-0308-1155"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Histology, Embryology and Cytogenetic, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat 10100, Morocco. nasrelomari@gmail.com."}], "LastName": "El Omari", "ForeName": "Nasreddine", "Initials": "N"}, {"Identifier": ["0000-0002-9024-4898"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Zoology and General Biology, Faculty of Sciences, Mohammed V University, Rabat 10106, Morocco. balahbib.abdo@gmail.com."}], "LastName": "Balahbib", "ForeName": "Abdelaali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1991953381, Iran. taaheri.yasaman@gmail.com."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran 11369, Iran. taaheri.yasaman@gmail.com."}], "LastName": "Taheri", "ForeName": "Yasaman", "Initials": "Y"}, {"Identifier": ["0000-0001-9317-1631"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, and Genomic Center of Human Pathologies, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat 10106, Morocco. boyahyaa-90@hotmail.fr."}], "LastName": "Bouyahya", "ForeName": "Abdelhakim", "Initials": "A"}, {"Identifier": ["0000-0003-3183-7623"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition and Dietetics, Faculty of Pharmacy, University of Concepcion, Concepcion 4070386, Chile. mmartorell@udec.cl."}, {"Identifier": [], "Affiliation": "Universidad de Concepci\u00f3n, Unidad de Desarrollo Tecnol\u00f3gico, UDT, Concepcion 4070386, Chile. mmartorell@udec.cl."}], "LastName": "Martorell", "ForeName": "Miquel", "Initials": "M"}, {"Identifier": ["0000-0002-5934-5201"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, University of Porto, Alameda Prof. Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal. ncmartins@med.up.pt."}, {"Identifier": [], "Affiliation": "Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal. ncmartins@med.up.pt."}], "LastName": "Martins", "ForeName": "Nat\u00e1lia", "Initials": "N"}, {"Identifier": ["0000-0003-4174-4586"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China. chocs@ha.org.hk."}], "LastName": "Cho", "ForeName": "William C", "Initials": "WC"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Drug Approval"}, {"QualifierName": [], "DescriptorName": "Humans"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "National Cancer Institute  Cancer Statistics.  [(accessed on 31 December 2017)]; Available online:  https://www.cancer.gov/about-cancer/understanding/"}, {"Citation": "World Health Organization (WHO)  Cancer: Fact Sheet.  [(accessed on 31 December 2017)]; Available online:  http://www.who.int/mediacentre/factsheets/fs297/en."}, {"Citation": "Cho W.C. Molecular connections of aging and cancer. Aging Dis. 2017;8:685\u2013687. doi: 10.14336/AD.2017.0822.", "ArticleIdList": ["10.14336/AD.2017.0822", "PMC5614330", "28966810"]}, {"Citation": "Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., et al. A review of human carcinogens\u2014Part B: biological agents. Lancet Oncol. 2009;10:321\u2013322. doi: 10.1016/S1470-2045(09)70096-8.", "ArticleIdList": ["10.1016/S1470-2045(09)70096-8", "19350698"]}, {"Citation": "Soares J.P., Cortinhas A., Bento T., Leitao J.C., Collins A.R., Gaivao I., Mota M.P. Aging and DNA damage in humans: a meta-analysis study. Aging. 2014;6:432\u2013439. doi: 10.18632/aging.100667.", "ArticleIdList": ["10.18632/aging.100667", "PMC4100806", "25140379"]}, {"Citation": "Lombard D.B., Chua K.F., Mostoslavsky R., Franco S., Gostissa M., Alt F.W. DNA repair, genome stability, and aging. Cell. 2005;120:497\u2013512. doi: 10.1016/j.cell.2005.01.028.", "ArticleIdList": ["10.1016/j.cell.2005.01.028", "15734682"]}, {"Citation": "Ma X., Wang Z. Anticancer drug discovery in the future: An evolutionary perspective. Drug Discov. Today. 2009;14:1136\u20131142. doi: 10.1016/j.drudis.2009.09.006.", "ArticleIdList": ["10.1016/j.drudis.2009.09.006", "19800414"]}, {"Citation": "Widmer N., Bardin C., Chatelut E., Paci A., Beijnen J., Leveque D., Veal G., Astier A. Review of therapeutic drug monitoring of anticancer drugs part two\u2014targeted therapies. Eur. J. Cancer. 2014;50:2020\u20132036. doi: 10.1016/j.ejca.2014.04.015.", "ArticleIdList": ["10.1016/j.ejca.2014.04.015", "24928190"]}, {"Citation": "Kuczynski E.A., Sargent D.J., Grothey A., Kerbel R.S. Drug rechallenge and treatment beyond progression\u2014implications for drug resistance. Nat. Rev. Clin. Oncol. 2013;10:571\u2013587. doi: 10.1038/nrclinonc.2013.158.", "ArticleIdList": ["10.1038/nrclinonc.2013.158", "PMC4540602", "23999218"]}, {"Citation": "Check Hayden E. Cancer complexity slows quest for cure. Nature. 2008;455:148. doi: 10.1038/455148a.", "ArticleIdList": ["10.1038/455148a", "18784686"]}, {"Citation": "Jung K.H., Noh J.H., Kim J.K., Eun J.W., Bae H.J., Chang Y.G., Kim M.G., Park W.S., Lee J.Y., Lee S.Y., et al. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer. Hepatology. 2012;56:644\u2013657. doi: 10.1002/hep.25699.", "ArticleIdList": ["10.1002/hep.25699", "22392728"]}, {"Citation": "Aggarwal B., Prasad S., Sung B., Krishnan S., Guha S. Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature. Curr. Colorectal Cancer Rep. 2013;9:37\u201356. doi: 10.1007/s11888-012-0154-1.", "ArticleIdList": ["10.1007/s11888-012-0154-1", "PMC3693477", "23814530"]}, {"Citation": "Pike M.C., Spicer D.V., Dahmoush L., Press M.F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 1993;15:17\u201335. doi: 10.1093/oxfordjournals.epirev.a036102.", "ArticleIdList": ["10.1093/oxfordjournals.epirev.a036102", "8405201"]}, {"Citation": "Yamane K., Tateishi K., Klose R.J., Fang J., Fabrizio L.A., Erdjument-Bromage H., Taylor-Papadimitriou J., Tempst P., Zhang Y. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell. 2007;25:801\u2013812. doi: 10.1016/j.molcel.2007.03.001.", "ArticleIdList": ["10.1016/j.molcel.2007.03.001", "17363312"]}, {"Citation": "Shoeb M. Anticancer agents from medicinal plants. Bangladesh J. Pharmacol. 2008;1:35\u201341. doi: 10.3329/bjp.v1i2.486.", "ArticleIdList": ["10.3329/bjp.v1i2.486"]}, {"Citation": "Newman D.J., Cragg G.M. Drugs and Drug Candidates from marine sources: An assessment of the current \u201cstate of play\u201d. Planta Med. 2016;82:775\u2013789. doi: 10.1055/s-0042-101353.", "ArticleIdList": ["10.1055/s-0042-101353", "26891002"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Balunas M.J., Kinghorn A.D. Drug discovery from medicinal plants. Life Sci. 2005;78:431\u2013441. doi: 10.1016/j.lfs.2005.09.012.", "ArticleIdList": ["10.1016/j.lfs.2005.09.012", "16198377"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;100:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Burns J., Yokota T., Ashihara H., Lean M.E., Crozier A. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 2002;50:3337\u20133340. doi: 10.1021/jf0112973.", "ArticleIdList": ["10.1021/jf0112973", "12010007"]}, {"Citation": "Mans D.R., da Rocha A.B., Schwartsmann G. Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist. 2000;5:185\u2013198. doi: 10.1634/theoncologist.5-3-185.", "ArticleIdList": ["10.1634/theoncologist.5-3-185", "10884497"]}, {"Citation": "Somasundaram S., Edmund N.A., Moore D.T., Small G.W., Shi Y.Y., Orlowski R.Z. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002;62:3868\u20133875.", "ArticleIdList": ["12097302"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012;75:311\u2013335. doi: 10.1021/np200906s.", "ArticleIdList": ["10.1021/np200906s", "PMC3721181", "22316239"]}, {"Citation": "Cragg G.M., Grothaus P.G., Newman D.J. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 2009;109:3012\u20133043. doi: 10.1021/cr900019j.", "ArticleIdList": ["10.1021/cr900019j", "19422222"]}, {"Citation": "Grothaus P.G., Cragg G.M., Newman D.J. Plant natural products in anticancer drug discovery. Curr. Org. Chem. 2010;14:1781\u20131791. doi: 10.2174/138527210792927708.", "ArticleIdList": ["10.2174/138527210792927708"]}, {"Citation": "Demain A.L., Vaishnav P. Natural products for cancer chemotherapy. Microb. Biotechnol. 2011;4:687\u2013699. doi: 10.1111/j.1751-7915.2010.00221.x.", "ArticleIdList": ["10.1111/j.1751-7915.2010.00221.x", "PMC3815406", "21375717"]}, {"Citation": "Basmadjian C., Zhao Q., Bentouhami E., Djehal A., Nebigil C.G., Johnson R.A., Serova M., de Gramont A., Faivre S., Raymond E., et al. Cancer wars: Natural products strike back. Front. Chem. 2014;2:20. doi: 10.3389/fchem.2014.00020.", "ArticleIdList": ["10.3389/fchem.2014.00020", "PMC4013484", "24822174"]}, {"Citation": "Cragg G.M., Newman D.J. Nature: A vital source of leads for anticancer drug development. Phytochem. Rev. 2009;8:313\u2013331. doi: 10.1007/s11101-009-9123-y.", "ArticleIdList": ["10.1007/s11101-009-9123-y"]}, {"Citation": "Sithranga Boopathy N., Kathiresan K. Anticancer drugs from marine flora: An overview. J. Oncol. 2010;2010:214186. doi: 10.1155/2010/214186.", "ArticleIdList": ["10.1155/2010/214186", "PMC3065217", "21461373"]}, {"Citation": "Kingston D.G.I. Modern natural products drug discovery and its relevance to biodiversity conservation. J. Nat. Prod. 2011;74:496\u2013511. doi: 10.1021/np100550t.", "ArticleIdList": ["10.1021/np100550t", "PMC3061248", "21138324"]}, {"Citation": "Jackson S.J., Murphy L.L., Venema R.C., Singletary K.W., Young A.J. Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation. Food Chem. Toxicol. 2013;60:431\u2013438. doi: 10.1016/j.fct.2013.08.008.", "ArticleIdList": ["10.1016/j.fct.2013.08.008", "PMC3954605", "23939039"]}, {"Citation": "Thangapazham R.L., Sharad S., Maheshwari R.K. Skin regenerative potentials of curcumin. Biofactors. 2013;39:141\u2013149. doi: 10.1002/biof.1078.", "ArticleIdList": ["10.1002/biof.1078", "23315856"]}, {"Citation": "Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009;41:40\u201359. doi: 10.1016/j.biocel.2008.06.010.", "ArticleIdList": ["10.1016/j.biocel.2008.06.010", "PMC2637808", "18662800"]}, {"Citation": "Chatterjee S.J., Pandey S. Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy. Cancer Biol. 2011;11:216\u2013228. doi: 10.4161/cbt.11.2.13798.", "ArticleIdList": ["10.4161/cbt.11.2.13798", "21088500"]}, {"Citation": "Malik S., Cusid\u00f3 R.M., Mirjalili M.H., Moyano E., Palaz\u00f3n J., Bonfill M. Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review. Process Biochem. 2011;46:23\u201334. doi: 10.1016/j.procbio.2010.09.004.", "ArticleIdList": ["10.1016/j.procbio.2010.09.004"]}, {"Citation": "Prota A.E., Bargsten K., Zurwerra D., Field J.J., Diaz J.F., Altmann K.H., Steinmetz M.O. Molecular mechanism of action of microtubule-stabilizing anticancer agents. Science. 2013;339:587\u2013590. doi: 10.1126/science.1230582.", "ArticleIdList": ["10.1126/science.1230582", "23287720"]}, {"Citation": "Ganguly A., Yang H., Cabral F. Paclitaxel-dependent cell lines reveal a novel drug activity. Mol. Cancer Ther. 2010;9:2914\u20132923. doi: 10.1158/1535-7163.MCT-10-0552.", "ArticleIdList": ["10.1158/1535-7163.MCT-10-0552", "PMC2978777", "20978163"]}, {"Citation": "Priyadarshini K., Aparajitha U.K. Paclitaxel against cancer: A short review. Med. Chem. 2012;2:139\u2013141. doi: 10.4172/2161-0444.1000130.", "ArticleIdList": ["10.4172/2161-0444.1000130"]}, {"Citation": "Morales-Cano D., Calvino E., Rubio V., Herraez A., Sancho P., Tejedor M.C., Diez J.C. Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition. Exp. Toxicol. Pathol. 2013;65:1101\u20131108. doi: 10.1016/j.etp.2013.04.006.", "ArticleIdList": ["10.1016/j.etp.2013.04.006", "23735541"]}, {"Citation": "Kunnumakkara A.B., Harsha C., Banik K., Vikkurthi R., Sailo B.L., Bordoloi D., Gupta S.C., Aggarwal B.B. Is curcumin bioavailability a problem in humans: Lessons from clinical trials. Expert Opin. Drug Metab. Toxicol. 2019;15:705\u2013733. doi: 10.1080/17425255.2019.1650914.", "ArticleIdList": ["10.1080/17425255.2019.1650914", "31361978"]}, {"Citation": "Costa-Lotufo L.V., Wilke D.V., Jimenez P.C., Epifanio R.d.A. Organismos marinhos como fonte de novos f\u00e1rmacos: Hist\u00f3rico & perspectivas. Qu\u00edmica Nova. 2009;32:703\u2013716."}, {"Citation": "La Clair J.J. Natural product mode of action (MOA) studies: A link between natural and synthetic worlds. Nat. Prod. Rep. 2010;27:969\u2013995. doi: 10.1039/b909989c.", "ArticleIdList": ["10.1039/b909989c", "20422068"]}, {"Citation": "Carlson E.E. Natural products as chemical probes. Acs Chem. Biol. 2010;5:639\u2013653. doi: 10.1021/cb100105c.", "ArticleIdList": ["10.1021/cb100105c", "PMC2926141", "20509672"]}, {"Citation": "Valli M., dos Santos R.N., Figueira L.D., Nakajima C.H., Castro-Gamboa I., Andricopulo A.D., Bolzani V.S. Development of a natural products database from the biodiversity of Brazil. J. Nat. Prod. 2013;76:439\u2013444. doi: 10.1021/np3006875.", "ArticleIdList": ["10.1021/np3006875", "23330984"]}, {"Citation": "Cragg G.M., Grothaus P.G., Newman D.J. New horizons for old drugs and drug leads. J. Nat. Prod. 2014;77:703\u2013723. doi: 10.1021/np5000796.", "ArticleIdList": ["10.1021/np5000796", "24499205"]}, {"Citation": "Gerwick W.H., Moore B.S. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chem. Biol. 2012;19:85\u201398. doi: 10.1016/j.chembiol.2011.12.014.", "ArticleIdList": ["10.1016/j.chembiol.2011.12.014", "PMC3345185", "22284357"]}, {"Citation": "Montaser R., Luesch H. Marine natural products: A new wave of drugs? Future Med. Chem. 2011;3:1475\u20131489. doi: 10.4155/fmc.11.118.", "ArticleIdList": ["10.4155/fmc.11.118", "PMC3210699", "21882941"]}, {"Citation": "Imhoff J.F., Labes A., Wiese J. Bio-mining the microbial treasures of the ocean: New natural products. Biotechnol. Adv. 2011;29:468\u2013482. doi: 10.1016/j.biotechadv.2011.03.001.", "ArticleIdList": ["10.1016/j.biotechadv.2011.03.001", "21419836"]}, {"Citation": "World Health Organization (WHO) Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Int. Agency Res. Cancer. 2018;263"}, {"Citation": "Yan S.-H. An early history of human breast cancer: West meets East. Chin. J. Cancer. 2013;32:475. doi: 10.5732/cjc.013.10097.", "ArticleIdList": ["10.5732/cjc.013.10097", "PMC3845566", "23958056"]}, {"Citation": "Sudhakar A. History of cancer, ancient and modern treatment methods. J. Cancer Sci. 2009;1:1. doi: 10.4172/1948-5956.100000e2.", "ArticleIdList": ["10.4172/1948-5956.100000e2", "20740081"]}, {"Citation": "Ghosh S.K. Giovanni Battista Morgagni (1682\u20131771): Father of pathologic anatomy and pioneer of modern medicine. Anat. Sci. Int. 2017;92:305\u2013312. doi: 10.1007/s12565-016-0373-7.", "ArticleIdList": ["10.1007/s12565-016-0373-7", "27629485"]}, {"Citation": "Dobson J. John Hunter\u2019s views on cancer. Ann. R. Coll. Surg. Engl. 1959;25:176.", "ArticleIdList": ["PMC2413782", "13817098"]}, {"Citation": "Walter E., Scott M. The life and work of Rudolf Virchow 1821\u20131902: \u201cCell theory, thrombosis and the sausage duel\u201d. J. Intensive Care Soc. 2017;18:234\u2013235. doi: 10.1177/1751143716663967.", "ArticleIdList": ["10.1177/1751143716663967", "PMC5665122", "29118836"]}, {"Citation": "Papac R.J. Origins of cancer therapy. Yale J. Biol. Med. 2001;74:391.", "ArticleIdList": ["PMC2588755", "11922186"]}, {"Citation": "Kaufmann S.H. Paul Ehrlich: Founder of chemotherapy. Nat. Rev. Drug Discov. 2008;7:373. doi: 10.1038/nrd2582.", "ArticleIdList": ["10.1038/nrd2582", "18456958"]}, {"Citation": "DeVita V.T., Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68:8643\u20138653. doi: 10.1158/0008-5472.CAN-07-6611.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-6611", "18974103"]}, {"Citation": "Avenda\u00f1o C., Menendez J.C. Medicinal chemistry of anticancer drugs. Elsevier; Amsterdam, The Netherlands: 2015."}, {"Citation": "Kinch M.S. An analysis of FDA-approved drugs for oncology. Drug Discov. Today. 2014;19:1831\u20131835. doi: 10.1016/j.drudis.2014.08.007.", "ArticleIdList": ["10.1016/j.drudis.2014.08.007", "25172803"]}, {"Citation": "Magalh\u00e3es L.G., Ferreira L.L., Andricopulo A.D. Recent advances and perspectives in cancer drug design. Da Acad. Bras. De Ci\u00eancias. 2018;90:1233\u20131250.", "ArticleIdList": ["29768576"]}, {"Citation": "Williams C.T. Food and Drug Administration drug approval process: a history and overview. Nurs. Clin. 2016;51:1\u201311. doi: 10.1016/j.cnur.2015.10.007.", "ArticleIdList": ["10.1016/j.cnur.2015.10.007", "26897420"]}, {"Citation": "Bishayee A., Sethi G. Bioactive natural products in cancer prevention and therapy: Progress and promise. Semin. Cancer Biol. 2016;40\u201341:1\u20133. doi: 10.1016/j.semcancer.2016.08.006.", "ArticleIdList": ["10.1016/j.semcancer.2016.08.006", "27565447"]}, {"Citation": "Nightingale G., Ryu J. Cabazitaxel (jevtana): A novel agent for metastatic castration-resistant prostate cancer. Pharm. Ther. 2012;37:440.", "ArticleIdList": ["PMC3474423", "23091336"]}, {"Citation": "Pal S.K., Twardowski P., Sartor O. Critical appraisal of cabazitaxel in the management of advanced prostate cancer. Clin. Interv. Aging. 2010;5:395. doi: 10.2147/CIA.S14570.", "ArticleIdList": ["10.2147/CIA.S14570", "PMC2998247", "21152241"]}, {"Citation": "Hirata Y., Uemura D. Halichondrins-antitumor polyether macrolides from a marine sponge. Pure Appl. Chem. 1986;58:701\u2013710. doi: 10.1351/pac198658050701.", "ArticleIdList": ["10.1351/pac198658050701"]}, {"Citation": "Towle M.J., Salvato K.A., Budrow J., Wels B.F., Kuznetsov G., Aalfs K.K., Welsh S., Zheng W., Seletsky B.M., Palme M.H. In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. Cancer Res. 2001;61:1013\u20131021.", "ArticleIdList": ["11221827"]}, {"Citation": "Aicher T.D., Buszek K.R., Fang F.G., Forsyth C.J., Jung S.H., Kishi Y., Matelich M.C., Scola P.M., Spero D.M., Yoon S.K. Total synthesis of halichondrin B and norhalichondrin B. J. Am. Chem. Soc. 1992;114:3162\u20133164. doi: 10.1021/ja00034a086.", "ArticleIdList": ["10.1021/ja00034a086"]}, {"Citation": "Wang Y., Habgood G.J., Christ W.J., Kishi Y., Littlefield B.A., Melvin J.Y. Structure\u2013activity relationships of halichondrin B analogues: modifications at C. 30\u2013C. 38. Bioorg. Med. Chem. Lett. 2000;10:1029\u20132032. doi: 10.1016/S0960-894X(00)00150-5.", "ArticleIdList": ["10.1016/S0960-894X(00)00150-5", "10843209"]}, {"Citation": "Bai R., Paull K.D., Herald C.L., Malspeis L., Pettit G.R., Hamel E. Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J. Biol. Chem. 1991;266:15882\u201315889.", "ArticleIdList": ["1874739"]}, {"Citation": "Stamos D.P., Chen S.S., Kishi Y. New Synthetic Route to the C. 14\u2212 C. 38 Segment of Halichondrins. J. Org. Chem. 1997;62:7552\u20137553. doi: 10.1021/jo971713b.", "ArticleIdList": ["10.1021/jo971713b"]}, {"Citation": "Jordan M.A., Kamath K., Manna T., Okouneva T., Miller H.P., Davis C., Littlefield B.A., Wilson L. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth. Mol. Cancer. Ther. 2005;4:1086\u20131095. doi: 10.1158/1535-7163.MCT-04-0345.", "ArticleIdList": ["10.1158/1535-7163.MCT-04-0345", "16020666"]}, {"Citation": "Dabydeen D.A., Burnett J.C., Bai R., Verdier-Pinard P., Hickford S.J., Pettit G.R., Blunt J.W., Munro M.H., Gussio R., Hamel E. Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin. Mol. Pharm. 2006;70:1866\u20131875. doi: 10.1124/mol.106.026641.", "ArticleIdList": ["10.1124/mol.106.026641", "16940412"]}, {"Citation": "Alday P.H., Correia J.J. Macromolecular interaction of halichondrin B analogues eribulin (E7389) and ER-076349 with tubulin by analytical ultracentrifugation. Biochemistry. 2009;48:7927\u20137938. doi: 10.1021/bi900776u.", "ArticleIdList": ["10.1021/bi900776u", "19586046"]}, {"Citation": "Okouneva T., Azarenko O., Wilson L., Littlefield B.A., Jordan M.A. Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase. Mol. Cancer Ther. 2008;7:2003\u20132011. doi: 10.1158/1535-7163.MCT-08-0095.", "ArticleIdList": ["10.1158/1535-7163.MCT-08-0095", "PMC2562299", "18645010"]}, {"Citation": "Kuznetsov G., Towle M.J., Cheng H., Kawamura T., TenDyke K., Liu D., Kishi Y., Melvin J.Y., Littlefield B.A. Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389. Cancer Res. 2004;64:5760\u20135766. doi: 10.1158/0008-5472.CAN-04-1169.", "ArticleIdList": ["10.1158/0008-5472.CAN-04-1169", "15313917"]}, {"Citation": "Johnson I.S., Armstrong J.G., Gorman M., Burnett J.P. The vinca alkaloids: A new class of oncolytic agents. Cancer Res. 1963;23", "ArticleIdList": ["14070392"]}, {"Citation": "Noble R.L. The discovery of the vinca alkaloids\u2014chemotherapeutic agents against cancer. Biochem. Cell Biol. 1990;68:1344\u20131351. doi: 10.1139/o90-197.", "ArticleIdList": ["10.1139/o90-197", "2085431"]}, {"Citation": "Noble R., Beer C., Cutts J. Role of chance observations in chemotherapy: Vinca rosea. Ann. N. Y. Acad. Sci. 1958;76:882\u2013894. doi: 10.1111/j.1749-6632.1958.tb54906.x.", "ArticleIdList": ["10.1111/j.1749-6632.1958.tb54906.x", "13627916"]}, {"Citation": "Silverman J.A., Deitcher S.R. Marqibo\u00ae (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemother. Pharm. 2013;71:555\u2013564. doi: 10.1007/s00280-012-2042-4.", "ArticleIdList": ["10.1007/s00280-012-2042-4", "PMC3579462", "23212117"]}, {"Citation": "Morales J., Li L., Fattah F.J., Dong Y., Bey E.A., Patel M., Gao J., Boothman D.A. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit. Rev. TM Eukaryot. Gene Expr. 2014;24 doi: 10.1615/CritRevEukaryotGeneExpr.2013006875.", "ArticleIdList": ["10.1615/CritRevEukaryotGeneExpr.2013006875", "PMC4806654", "24579667"]}, {"Citation": "Jenner Z.B., Sood A.K., Coleman R.L. Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy. Future Oncol. 2016;12:1439\u20131456. doi: 10.2217/fon-2016-0002.", "ArticleIdList": ["10.2217/fon-2016-0002", "PMC4976841", "27087632"]}, {"Citation": "Mirza M.R., Monk B.J., Herrstedt J., Oza A.M., Mahner S., Redondo A., Fabbro M., Ledermann J.A., Lorusso D., Vergote I. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N. Engl. J. Med. 2016;375:2154\u20132164. doi: 10.1056/NEJMoa1611310.", "ArticleIdList": ["10.1056/NEJMoa1611310", "27717299"]}, {"Citation": "McCann K.E. Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: Talazoparib. Future Oncol. 2019;15:1707\u20131715. doi: 10.2217/fon-2018-0751.", "ArticleIdList": ["10.2217/fon-2018-0751", "30912451"]}, {"Citation": "Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002;420:860. doi: 10.1038/nature01322.", "ArticleIdList": ["10.1038/nature01322", "PMC2803035", "12490959"]}, {"Citation": "Murata M. Inflammation and cancer. Environ. Health Prev. Med. 2018;23:50. doi: 10.1186/s12199-018-0740-1.", "ArticleIdList": ["10.1186/s12199-018-0740-1", "PMC6195709", "30340457"]}, {"Citation": "Kapche D.W., Lekane N.M., Kulabas S.S., Ipek H., Tok T.T., Ngadjui B.T., Demirtas I., Tumer T.B. Aryl benzofuran derivatives from the stem bark of Calpocalyx dinklagei attenuate inflammation. Phytochemistry. 2017;141:70\u201379. doi: 10.1016/j.phytochem.2017.05.007.", "ArticleIdList": ["10.1016/j.phytochem.2017.05.007", "28577435"]}, {"Citation": "Tumer T.B., Y\u0131lmaz B., Ozleyen A., Kurt B., Tok T.T., Taskin K.M., Kulabas S.S. GR24, a synthetic analog of Strigolactones, alleviates inflammation and promotes Nrf2 cytoprotective response: In vitro and in silico evidences. Comput. Biol. Chem. 2018;76:179\u2013190. doi: 10.1016/j.compbiolchem.2018.07.014.", "ArticleIdList": ["10.1016/j.compbiolchem.2018.07.014", "30048925"]}, {"Citation": "Crusz S.M., Balkwill F.R. Inflammation and cancer: Advances and new agents. Nat. Rev. Clin. Oncol. 2015;12:584. doi: 10.1038/nrclinonc.2015.105.", "ArticleIdList": ["10.1038/nrclinonc.2015.105", "26122183"]}, {"Citation": "Kulabas S., Ipek H., Tufekci A., Arslan S., Demirtas I., Ekren R., Sezerman U., Tumer T. Ameliorative potential of Lavandula stoechas in metabolic syndrome via multitarget interactions. J. Ethnopharmacol. 2018;223:88\u201398. doi: 10.1016/j.jep.2018.04.043.", "ArticleIdList": ["10.1016/j.jep.2018.04.043", "29729383"]}, {"Citation": "McCurdy A.R., Lacy M.Q. Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: An update for the hematologist. Ther. Adv. Hematol. 2013;4:211\u2013216. doi: 10.1177/2040620713480155.", "ArticleIdList": ["10.1177/2040620713480155", "PMC3666447", "23730498"]}, {"Citation": "Morabito F., Skafi M., Recchia A.G., Kashkeesh A., Hindiyeh M., Sabatleen A., Morabito L., Alijanazreh H., Hamamreh Y., Gentile M. Lenalidomide for the treatment of mantle cell lymphoma. Expert Opin. Pharmacother. 2019:1\u20138. doi: 10.1080/14656566.2018.1561865.", "ArticleIdList": ["10.1080/14656566.2018.1561865", "30608891"]}, {"Citation": "Hideshima T., Raje N., Richardson P.G., Anderson K.C. A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma. Ther. Clin. Risk Manag. 2008;4:129. doi: 10.2147/TCRM.S1445.", "ArticleIdList": ["10.2147/TCRM.S1445", "PMC2503648", "18728702"]}, {"Citation": "Butti R., Das S., Gunasekaran V.P., Yadav A.S., Kumar D., Kundu G.C. Receptor tyrosine kinases (RTKs) in breast cancer: Signaling, therapeutic implications and challenges. Mol. Cancer. 2018;17:34. doi: 10.1186/s12943-018-0797-x.", "ArticleIdList": ["10.1186/s12943-018-0797-x", "PMC5817867", "29455658"]}, {"Citation": "Du Z., Lovly C.M. Mechanisms of receptor tyrosine kinase activation in cancer. Mol. Cancer. 2018;17:58. doi: 10.1186/s12943-018-0782-4.", "ArticleIdList": ["10.1186/s12943-018-0782-4", "PMC5817791", "29455648"]}, {"Citation": "Vlahovic G., Crawford J. Activation of tyrosine kinases in cancer. Oncologist. 2003;8:531\u2013538. doi: 10.1634/theoncologist.8-6-531.", "ArticleIdList": ["10.1634/theoncologist.8-6-531", "14657531"]}, {"Citation": "Takeuchi K., Ito F. Receptor tyrosine kinases and targeted cancer therapeutics. Biol. Pharm. Bull. 2011;34:1774\u20131780. doi: 10.1248/bpb.34.1774.", "ArticleIdList": ["10.1248/bpb.34.1774", "22130229"]}, {"Citation": "Nishina T., Takahashi S., Iwasawa R., Noguchi H., Aoki M., Doi T. Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors. Investig. New Drugs. 2018;36:424\u2013434. doi: 10.1007/s10637-017-0514-4.", "ArticleIdList": ["10.1007/s10637-017-0514-4", "28965185"]}, {"Citation": "Haugsten E.M., Wiedlocha A., Olsnes S., Wesche J. Roles of fibroblast growth factor receptors in carcinogenesis. Mol. Cancer Res. 2010;8:1439\u20131452. doi: 10.1158/1541-7786.MCR-10-0168.", "ArticleIdList": ["10.1158/1541-7786.MCR-10-0168", "21047773"]}, {"Citation": "Scott L.J. Lenvatinib: First global approval. Drugs. 2015;75:553\u2013560. doi: 10.1007/s40265-015-0383-0.", "ArticleIdList": ["10.1007/s40265-015-0383-0", "25795101"]}, {"Citation": "Verheul H.M., Pinedo H.M. The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGFReceptor kinase inhibitors. Clin. Breast Cancer. 2000;1:S80\u2013S84. doi: 10.3816/CBC.2000.s.015.", "ArticleIdList": ["10.3816/CBC.2000.s.015", "11970755"]}, {"Citation": "Kelly R.J., Rixe O. Axitinib\u2014a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor. Target. Oncol. 2009;4:297\u2013305. doi: 10.1007/s11523-009-0126-9.", "ArticleIdList": ["10.1007/s11523-009-0126-9", "19876699"]}, {"Citation": "DrugBank  The Drug Database.  [(accessed on 31 October 2019)]; Available online:  https://www.drugbank.ca/"}, {"Citation": "Dimitrov D.S. Therapeutic Proteins. Springer; Totowa, NJ, USA: 2012. Therapeutic proteins; pp. 1\u201326."}, {"Citation": "Lagass\u00e9 H.D., Alexaki A., Simhadri V.L., Katagiri N.H., Jankowski W., Sauna Z.E., Kimchi-Sarfaty C. Recent advances in (therapeutic protein) drug development. F1000Research. 2017;6:113. doi: 10.12688/f1000research.9970.1.", "ArticleIdList": ["10.12688/f1000research.9970.1", "PMC5302153", "28232867"]}, {"Citation": "Zhu J. Mammalian cell protein expression for biopharmaceutical production. Biotechnol. Adv. 2012;30:1158\u20131170. doi: 10.1016/j.biotechadv.2011.08.022.", "ArticleIdList": ["10.1016/j.biotechadv.2011.08.022", "21968146"]}, {"Citation": "Tai W., Mahato R., Cheng K. The role of HER2 in cancer therapy and targeted drug delivery. J. Control. Release. 2010;146:264\u2013275. doi: 10.1016/j.jconrel.2010.04.009.", "ArticleIdList": ["10.1016/j.jconrel.2010.04.009", "PMC2918695", "20385184"]}, {"Citation": "Gunturu K.S., Woo Y., Beaubier N., Remotti H.E., Saif M.W. Gastric cancer and trastuzumab: First biologic therapy in gastric cancer. Ther. Adv. Med Oncol. 2013;5:143\u2013151. doi: 10.1177/1758834012469429.", "ArticleIdList": ["10.1177/1758834012469429", "PMC3556876", "23450234"]}, {"Citation": "Casak S.J., Fashoyin-Aje I., Lemery S.J., Zhang L., Jin R., Li H., Zhao L., Zhao H., Zhang H., Chen H. FDA approval summary: Ramucirumab for gastric cancer. Clin. Cancer Res. 2015;21:3372\u20133376. doi: 10.1158/1078-0432.CCR-15-0600.", "ArticleIdList": ["10.1158/1078-0432.CCR-15-0600", "26048277"]}, {"Citation": "Vora C., Gupta S. Targeted therapy in cervical cancer. Esmo Open. 2019;3:e000462. doi: 10.1136/esmoopen-2018-000462.", "ArticleIdList": ["10.1136/esmoopen-2018-000462", "PMC6438352", "30997156"]}, {"Citation": "The Nobel Prize in Physiology or Medicine.  [(accessed on 31 October 2019)];2018  Available online:  https://www.nobelprize.org/prizes/medicine/2018/summary/"}, {"Citation": "Hammerich L., Binder A., Brody J.D. In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf. Mol. Oncol. 2015;9:1966\u20131981. doi: 10.1016/j.molonc.2015.10.016.", "ArticleIdList": ["10.1016/j.molonc.2015.10.016", "PMC5528727", "26632446"]}, {"Citation": "Kwon E.D., Hurwitz A.A., Foster B.A., Madias C., Feldhaus A.L., Greenberg N.M., Burg M.B., Allison J.P. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA. 1997;94:8099\u20138103. doi: 10.1073/pnas.94.15.8099.", "ArticleIdList": ["10.1073/pnas.94.15.8099", "PMC21563", "9223321"]}, {"Citation": "Hodi F.S., Mihm M.C., Soiffer R.J., Haluska F.G., Butler M., Seiden M.V., Davis T., Henry-Spires R., MacRae S., Willman A. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl. Acad. Sci. USA. 2003;100:4712\u20134717. doi: 10.1073/pnas.0830997100.", "ArticleIdList": ["10.1073/pnas.0830997100", "PMC153621", "12682289"]}, {"Citation": "Leach D.R., Krummel M.F., Allison J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science (N. Y.) 1996;271:1734\u20131736. doi: 10.1126/science.271.5256.1734.", "ArticleIdList": ["10.1126/science.271.5256.1734", "8596936"]}, {"Citation": "Hodi F.S., O\u2019Day S.J., McDermott D.F., Weber R.W., Sosman J.A., Haanen J.B., Gonzalez R., Robert C., Schadendorf D., Hassel J.C. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 2010;363:711\u2013723. doi: 10.1056/NEJMoa1003466.", "ArticleIdList": ["10.1056/NEJMoa1003466", "PMC3549297", "20525992"]}, {"Citation": "Johnson D.B., Peng C., Abramson R.G., Ye F., Zhao S., Wolchok J.D., Sosman J.A., Carvajal R.D., Ariyan C.E. Clinical activity of ipilimumab in acral melanoma: A retrospective review. Oncologist. 2015;20:648\u2013652. doi: 10.1634/theoncologist.2014-0468.", "ArticleIdList": ["10.1634/theoncologist.2014-0468", "PMC4571784", "25964307"]}, {"Citation": "Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000;192:1027\u20131034. doi: 10.1084/jem.192.7.1027.", "ArticleIdList": ["10.1084/jem.192.7.1027", "PMC2193311", "11015443"]}, {"Citation": "Poole R.M. Pembrolizumab: First global approval. Drugs. 2014;74:1973\u20131981. doi: 10.1007/s40265-014-0314-5.", "ArticleIdList": ["10.1007/s40265-014-0314-5", "25331768"]}, {"Citation": "FDA Approval.  [(accessed on 31 October 2019)]; Available online:  https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-ipilimumab-msi-h-or-dmmr-metastatic-colorectal-cancer."}, {"Citation": "Massard C., Gordon M.S., Sharma S., Rafii S., Wainberg Z.A., Luke J., Curiel T.J., Colon-Otero G., Hamid O., Sanborn R.E. Safety and efficacy of durvalumab (MEDI4736), an anti\u2013programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer. J. Clin. Oncol. 2016;34:3119. doi: 10.1200/JCO.2016.67.9761.", "ArticleIdList": ["10.1200/JCO.2016.67.9761", "PMC5569690", "27269937"]}, {"Citation": "Markham A. Atezolizumab: first global approval. Drugs. 2016;76:1227\u20131232. doi: 10.1007/s40265-016-0618-8.", "ArticleIdList": ["10.1007/s40265-016-0618-8", "27412122"]}, {"Citation": "Diamantis N., Banerji U. Antibody-drug conjugates\u2014an emerging class of cancer treatment. Br. J. Cancer. 2016;114:362. doi: 10.1038/bjc.2015.435.", "ArticleIdList": ["10.1038/bjc.2015.435", "PMC4815767", "26742008"]}, {"Citation": "Tsuchikama K., An Z. Antibody-drug conjugates: Recent advances in conjugation and linker chemistries. Protein Cell. 2018;9:33\u201346. doi: 10.1007/s13238-016-0323-0.", "ArticleIdList": ["10.1007/s13238-016-0323-0", "PMC5777969", "27743348"]}, {"Citation": "FDA Approval History.  [(accessed on 31 October 2019)]; Available online:  https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1254/kadcyla-ado-trastuzumab-emtansine."}, {"Citation": "Phillips G.D.L., Li G., Dugger D.L., Crocker L.M., Parsons K.L., Mai E., Bl\u00e4ttler W.A., Lambert J.M., Chari R.V., Lutz R.J. Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody\u2013cytotoxic drug conjugate. Cancer Res. 2008;68:9280\u20139290. doi: 10.1158/0008-5472.CAN-08-1776.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-1776", "19010901"]}, {"Citation": "Asparlas Approval History.  [(accessed on 31 October 2019)]; Available online:  https://www.drugs.com/history/asparlas.html."}, {"Citation": "Angiolillo A.L., Schore R.J., Devidas M., Borowitz M.J., Carroll A.J., Gastier-Foster J.M., Heerema N.A., Keilani T., Lane A.R., Loh M.L. Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: Results from Children\u2019s Oncology Group Study AALL07P4. J. Clin. Oncol. 2014;32:3874. doi: 10.1200/JCO.2014.55.5763.", "ArticleIdList": ["10.1200/JCO.2014.55.5763", "PMC4239306", "25348002"]}, {"Citation": "Mehta R.G., Murillo G., Naithani R., Peng X. Cancer chemoprevention by natural products: How far have we come? Pharm. Res. 2010;27:950\u2013961. doi: 10.1007/s11095-010-0085-y.", "ArticleIdList": ["10.1007/s11095-010-0085-y", "20238150"]}, {"Citation": "Huang W.Y., Cai Y.Z., Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: Potential use for cancer prevention. Nutr. Cancer. 2010;62:1\u201320. doi: 10.1080/01635580903191585.", "ArticleIdList": ["10.1080/01635580903191585", "20043255"]}, {"Citation": "Desai A.G., Qazi G.N., Ganju R.K., El-Tamer M., Singh J., Saxena A.K., Bedi Y.S., Taneja S.C., Bhat H.K. Medicinal plants and cancer chemoprevention. Curr. Drug Metab. 2008;9:581\u2013591. doi: 10.2174/138920008785821657.", "ArticleIdList": ["10.2174/138920008785821657", "PMC4160808", "18781909"]}, {"Citation": "Nagler R.M. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol. 2009;45:1006\u20131010. doi: 10.1016/j.oraloncology.2009.07.005.", "ArticleIdList": ["10.1016/j.oraloncology.2009.07.005", "19828359"]}, {"Citation": "Rahman M.A., Amin A.R., Shin D.M. Chemopreventive potential of natural compounds in head and neck cancer. Nutr. Cancer. 2010;62:973\u2013987. doi: 10.1080/01635581.2010.509538.", "ArticleIdList": ["10.1080/01635581.2010.509538", "PMC3744227", "20924973"]}, {"Citation": "Nam W., Tak J., Ryu J.K., Jung M., Yook J.I., Kim H.J., Cha I.H. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck. 2007;29:335\u2013340. doi: 10.1002/hed.20524.", "ArticleIdList": ["10.1002/hed.20524", "17163469"]}, {"Citation": "Datta R., Kojima H., Yoshida K., Kufe D. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 1997;272:20317\u201320320. doi: 10.1074/jbc.272.33.20317.", "ArticleIdList": ["10.1074/jbc.272.33.20317", "9252332"]}, {"Citation": "D\u2019Amours D., Germain M., Orth K., Dixit V.M., Poirier G.G. Proteolysis of poly(ADP-ribose) polymerase by caspase 3: Kinetics of cleavage of mono(ADP-ribosyl)ated and DNA-bound substrates. Radiat. Res. 1998;150:3\u201310. doi: 10.2307/3579638.", "ArticleIdList": ["10.2307/3579638", "9650595"]}, {"Citation": "Fujisawa S., Atsumi T., Satoh K., Kadoma Y., Ishihara M., Okada N., Nagasaki M., Yokoe I., Sakagami H. Radical generation, radical-scavenging activity, and cytotoxicity of eugenol-related compounds. Vitr. Mol. Toxicol. 2000;13:269\u2013280.", "ArticleIdList": ["11319278"]}, {"Citation": "Carrasco A.H., Espinoza C.L., Cardile V., Gallardo C., Cardona W., Lombardo L., Catal\u00e1n M.K., Cuellar F.M., Russo A. Eugenol and its synthetic analogues inhibit cell growth of human cancer cells (Part I) J. Braz. Chem. Soc. 2008;19:543\u2013548. doi: 10.1590/S0103-50532008000300024.", "ArticleIdList": ["10.1590/S0103-50532008000300024"]}, {"Citation": "Jeng J.H., Hahn L.J., Lu F.J., Wang Y.J., Kuo M.Y. Eugenol triggers different pathobiological effects on human oral mucosal fibroblasts. J. Dent. Res. 1994;73:1050\u20131055. doi: 10.1177/00220345940730050601.", "ArticleIdList": ["10.1177/00220345940730050601", "8006231"]}, {"Citation": "Ziech D., Anestopoulos I., Hanafi R., Voulgaridou G.P., Franco R., Georgakilas A.G., Pappa A., Panayiotidis M.I. Pleiotrophic effects of natural products in ROS-induced carcinogenesis: The role of plant-derived natural products in oral cancer chemoprevention. Cancer Lett. 2012;327:16\u201325. doi: 10.1016/j.canlet.2012.02.025.", "ArticleIdList": ["10.1016/j.canlet.2012.02.025", "22381695"]}, {"Citation": "Ni W.F., Tsai C.H., Yang S.F., Chang Y.C. Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts. Oral Oncol. 2007;43:557\u2013562. doi: 10.1016/j.oraloncology.2006.06.007.", "ArticleIdList": ["10.1016/j.oraloncology.2006.06.007", "16996785"]}, {"Citation": "Gopalakrishnan A., Tony Kong A.N. Anticarcinogenesis by dietary phytochemicals: Cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells. Food Chem. Toxicol. 2008;46:1257\u20131270. doi: 10.1016/j.fct.2007.09.082.", "ArticleIdList": ["10.1016/j.fct.2007.09.082", "17950513"]}, {"Citation": "Lin H.L., Liu T.Y., Wu C.W., Chi C.W. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel. Br. J. Cancer. 1999;81:416\u2013422. doi: 10.1038/sj.bjc.6690710.", "ArticleIdList": ["10.1038/sj.bjc.6690710", "PMC2362909", "10507765"]}, {"Citation": "Lin C.C., Yang J.S., Chen J.T., Fan S., Yu F.S., Yang J.L., Lu C.C., Kao M.C., Huang A.C., Lu H.F., et al. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res. 2007;27:3371\u20133378.", "ArticleIdList": ["17970083"]}, {"Citation": "Liang W.Z., Chou C.T., Lu T., Chi C.C., Tseng L.L., Pan C.C., Lin K.L., Kuo C.C., Jan C.R. The mechanism of carvacrol-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in OC2 human oral cancer cells. Toxicology. 2013;303:152\u2013161. doi: 10.1016/j.tox.2012.10.026.", "ArticleIdList": ["10.1016/j.tox.2012.10.026", "23146755"]}, {"Citation": "Sertel S., Eichhorn T., Plinkert P.K., Efferth T. Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. Anticancer Res. 2011;31:81\u201387.", "ArticleIdList": ["21273584"]}, {"Citation": "Sertel S., Eichhorn T., Plinkert P.K., Efferth T. [Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)] Hno. 2011;59:1203\u20131208. doi: 10.1007/s00106-011-2274-3.", "ArticleIdList": ["10.1007/s00106-011-2274-3", "21894557"]}, {"Citation": "Sertel S., Eichhorn T., Plinkert P.K., Efferth T. Chemical Composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Levisticum officinale, against UMSCC1 head and neck squamous carcinoma cells. Anticancer Res. 2011;31:185\u2013191.", "ArticleIdList": ["21273597"]}, {"Citation": "Manosroi J., Dhumtanom P., Manosroi A. Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. Cancer Lett. 2006;235:114\u2013120. doi: 10.1016/j.canlet.2005.04.021.", "ArticleIdList": ["10.1016/j.canlet.2005.04.021", "15979235"]}, {"Citation": "Cha J.D., Jeong M.R., Kim H.Y., Lee J.C., Lee K.Y. MAPK activation is necessary to the apoptotic death of KB cells induced by the essential oil isolated from Artemisia iwayomogi. J. Ethnopharmacol. 2009;123:308\u2013314. doi: 10.1016/j.jep.2009.03.002.", "ArticleIdList": ["10.1016/j.jep.2009.03.002", "19429377"]}, {"Citation": "Cha J.D., Moon S.E., Kim H.Y., Cha I.H., Lee K.Y. Essential oil of Artemisia capillaris induces apoptosis in KB cells via mitochondrial stress and caspase activation mediated by MAPK-stimulated signaling pathway. J. Food Sci. 2009;74:T75\u2013T81. doi: 10.1111/j.1750-3841.2009.01355.x.", "ArticleIdList": ["10.1111/j.1750-3841.2009.01355.x", "20492133"]}, {"Citation": "Keawsa-ard S., Liawruangrath B., Liawruangrath S., Teerawutgulrag A., Pyne S.G. Chemical constituents and antioxidant and biological activities of the essential oil from leaves of Solanum spirale. Nat. Prod. Commun. 2012;7:955\u2013958. doi: 10.1177/1934578X1200700740.", "ArticleIdList": ["10.1177/1934578X1200700740", "22908592"]}, {"Citation": "Edris A.E. Anti-cancer properties of Nigella spp. essential oils and their major constituents, thymoquinone and beta-elemene. Curr. Clin. Pharm. 2009;4:43\u201346. doi: 10.2174/157488409787236137.", "ArticleIdList": ["10.2174/157488409787236137", "19149500"]}, {"Citation": "Pisseri F., Bertoli A., Pistelli L. Essential oils in medicine: principles of therapy. Parassitologia. 2008;50:89\u201391.", "ArticleIdList": ["18693566"]}, {"Citation": "Seifried H.E., Anderson D.E., Fisher E.I., Milner J.A. A review of the interaction among dietary antioxidants and reactive oxygen species. J. Nutr. Biochem. 2007;18:567\u2013579. doi: 10.1016/j.jnutbio.2006.10.007.", "ArticleIdList": ["10.1016/j.jnutbio.2006.10.007", "17360173"]}, {"Citation": "Ziech D., Franco R., Georgakilas A.G., Georgakila S., Malamou-Mitsi V., Schoneveld O., Pappa A., Panayiotidis M.I. The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem.-Biol. Interact. 2010;188:334\u2013339. doi: 10.1016/j.cbi.2010.07.010.", "ArticleIdList": ["10.1016/j.cbi.2010.07.010", "20637748"]}, {"Citation": "Harish Kumar G., Vidya Priyadarsini R., Vinothini G., Vidjaya Letchoumy P., Nagini S. The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis. Investig. New Drugs. 2010;28:392\u2013401. doi: 10.1007/s10637-009-9263-3.", "ArticleIdList": ["10.1007/s10637-009-9263-3", "19458912"]}, {"Citation": "Hseu Y.C., Lee M.S., Wu C.R., Cho H.J., Lin K.Y., Lai G.H., Wang S.Y., Kuo Y.H., Kumar K.J., Yang H.L. The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway. J. Agric. Food Chem. 2012;60:2385\u20132397. doi: 10.1021/jf205053r.", "ArticleIdList": ["10.1021/jf205053r", "22324429"]}, {"Citation": "Su M., Chung H.Y., Li Y. Deoxyelephantopin from Elephantopus scaber L. induces cell-cycle arrest and apoptosis in the human nasopharyngeal cancer CNE cells. Biochem. Biophys. Res. Commun. 2011;411:342\u2013347. doi: 10.1016/j.bbrc.2011.06.144.", "ArticleIdList": ["10.1016/j.bbrc.2011.06.144", "21741953"]}, {"Citation": "Liang Z., Guo Y.T., Yi Y.J., Wang R.C., Hu Q.L., Xiong X.Y. Ganoderma lucidum polysaccharides target a Fas/caspase dependent pathway to induce apoptosis in human colon cancer cells. Asian Pac. J. Cancer Prev. 2014;15:3981\u20133986. doi: 10.7314/APJCP.2014.15.9.3981.", "ArticleIdList": ["10.7314/APJCP.2014.15.9.3981", "24935584"]}, {"Citation": "Thyagarajan A., Jedinak A., Nguyen H., Terry C., Baldridge L.A., Jiang J., Sliva D. Triterpenes from Ganoderma Lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK) Nutr. Cancer. 2010;62:630\u2013640. doi: 10.1080/01635580903532390.", "ArticleIdList": ["10.1080/01635580903532390", "20574924"]}, {"Citation": "Romano B., Borrelli F., Pagano E., Cascio M.G., Pertwee R.G., Izzo A.A. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. Phytomedicine. 2014;21:631\u2013639. doi: 10.1016/j.phymed.2013.11.006.", "ArticleIdList": ["10.1016/j.phymed.2013.11.006", "24373545"]}, {"Citation": "Yu Z., Li W., Liu F. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett. 2004;215:159\u2013166. doi: 10.1016/j.canlet.2004.06.010.", "ArticleIdList": ["10.1016/j.canlet.2004.06.010", "15488634"]}, {"Citation": "Luo Y., Wang S.X., Zhou Z.Q., Wang Z., Zhang Y.G., Zhang Y., Zhao P. Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF-kappaB) pathway. Tumour Biol. 2014;35:11483\u201311488. doi: 10.1007/s13277-014-2487-7.", "ArticleIdList": ["10.1007/s13277-014-2487-7", "25128065"]}, {"Citation": "Cha J.H., Kim W.K., Ha A.W., Kim M.H., Chang M.J. Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells. Nutr. Res. Pract. 2017;11:90\u201396. doi: 10.4162/nrp.2017.11.2.90.", "ArticleIdList": ["10.4162/nrp.2017.11.2.90", "PMC5376536", "28386381"]}, {"Citation": "Chen X.H., Miao Y.X., Wang X.J., Yu Z., Geng M.Y., Han Y.T., Wang L.X. Effects of Ginkgo biloba extract EGb761 on human colon adenocarcinoma cells. Cell. Physiol. Biochem. 2011;27:227\u2013232. doi: 10.1159/000327948.", "ArticleIdList": ["10.1159/000327948", "21471711"]}, {"Citation": "Lefort E.C., Blay J. The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells. Clin. Exp. Metastasis. 2011;28:337\u2013349. doi: 10.1007/s10585-010-9364-6.", "ArticleIdList": ["10.1007/s10585-010-9364-6", "21298326"]}, {"Citation": "Psahoulia F.H., Drosopoulos K.G., Doubravska L., Andera L., Pintzas A. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol. Cancer Ther. 2007;6:2591\u20132599. doi: 10.1158/1535-7163.MCT-07-0001.", "ArticleIdList": ["10.1158/1535-7163.MCT-07-0001", "17876056"]}, {"Citation": "Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 2011;61:212\u2013236. doi: 10.3322/caac.20121.", "ArticleIdList": ["10.3322/caac.20121", "21685461"]}, {"Citation": "World Health Organization (WHO)  Statistics on Brain Cancer.  [(accessed on 31 December 2018)]; Available online:  http://Www.Who.Int/Cancer/En/"}, {"Citation": "Salehi B., Fokou P.V.T., Yamthe L.R.T., Tali B.T., Adetunji C.O., Rahavian A., Mudau F.N., Martorell M., Setzer W.N., Rodrigues C.F., et al. Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents. Nutrients. 2019;11:1483. doi: 10.3390/nu11071483.", "ArticleIdList": ["10.3390/nu11071483", "PMC6683070", "31261861"]}, {"Citation": "Berkovich L., Earon G., Ron I., Rimmon A., Vexler A., Lev-Ari S. Moringa Oleifera aqueous leaf extract down-regulates nuclear factor-kappaB and increases cytotoxic effect of chemotherapy in pancreatic cancer cells. BMC Complement. Altern. Med. 2013;13:212. doi: 10.1186/1472-6882-13-212.", "ArticleIdList": ["10.1186/1472-6882-13-212", "PMC3765468", "23957955"]}, {"Citation": "Win N.N., Awale S., Esumi H., Tezuka Y., Kadota S. Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium. J. Nat. Prod. 2007;70:1582\u20131587. doi: 10.1021/np070286m.", "ArticleIdList": ["10.1021/np070286m", "17896818"]}, {"Citation": "Hafeez B.B., Jamal M.S., Fischer J.W., Mustafa A., Verma A.K. Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-kappaB signaling pathways. Int. J. Cancer. 2012;131:2175\u20132186. doi: 10.1002/ijc.27478.", "ArticleIdList": ["10.1002/ijc.27478", "PMC3522120", "22322442"]}, {"Citation": "Zalatnai A., Bocsi J. Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts. Anticancer Res. 2003;23:4007\u20134009.", "ArticleIdList": ["14666710"]}, {"Citation": "Shankar S., Ganapathy S., Hingorani S.R., Srivastava R.K. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front. Biosci. 2008;13:440\u2013452. doi: 10.2741/2691.", "ArticleIdList": ["10.2741/2691", "17981559"]}, {"Citation": "Chan L.L., George S., Ahmad I., Gosangari S.L., Abbasi A., Cunningham B.T., Watkin K.L. Cytotoxicity effects of amoora rohituka and chittagonga on breast and pancreatic cancer cells. Evid. -Based Complement. Altern. Med. 2011;2011:86060. doi: 10.1155/2011/860605.", "ArticleIdList": ["10.1155/2011/860605", "PMC3092714", "21584193"]}, {"Citation": "Awale S., Nakashima E.M., Kalauni S.K., Tezuka Y., Kurashima Y., Lu J., Esumi H., Kadota S. Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation. Bioorg. Med. Chem. Lett. 2006;16:581\u2013583. doi: 10.1016/j.bmcl.2005.10.046.", "ArticleIdList": ["10.1016/j.bmcl.2005.10.046", "16288865"]}, {"Citation": "Rifai Y., Arai M.A., Koyano T., Kowithayakorn T., Ishibashi M. Terpenoids and a flavonoid glycoside from Acacia pennata leaves as hedgehog/GLI-mediated transcriptional inhibitors. J. Nat. Prod. 2010;73:995\u2013997. doi: 10.1021/np1000818.", "ArticleIdList": ["10.1021/np1000818", "20450170"]}, {"Citation": "Drag M., Surowiak P., Drag-Zalesinska M., Dietel M., Lage H., Oleksyszyn J. Comparision of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines. Molecules. 2009;14:1639\u20131651. doi: 10.3390/molecules14041639.", "ArticleIdList": ["10.3390/molecules14041639", "PMC6254329", "19396022"]}, {"Citation": "Iwanski G.B., Lee D.H., En-Gal S., Doan N.B., Castor B., Vogt M., Toh M., Bokemeyer C., Said J.W., Thoennissen N.H., et al. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. Br. J. Pharm. 2010;160:998\u20131007. doi: 10.1111/j.1476-5381.2010.00741.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00741.x", "PMC2936004", "20590594"]}, {"Citation": "Rausch V., Liu L., Kallifatidis G., Baumann B., Mattern J., Gladkich J., Wirth T., Schemmer P., Buchler M.W., Zoller M., et al. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res. 2010;70:5004\u20135013. doi: 10.1158/0008-5472.CAN-10-0066.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-0066", "20530687"]}, {"Citation": "Zhou G.X., Ding X.L., Huang J.F., Zhang H., Wu S.B., Cheng J.P., Wei Q. Apoptosis of human pancreatic cancer cells induced by Triptolide. World J. Gastroenterol. 2008;14:1504\u20131509. doi: 10.3748/wjg.14.1504.", "ArticleIdList": ["10.3748/wjg.14.1504", "PMC2693742", "18330938"]}, {"Citation": "Anastyuk S.D., Shevchenko N.M., Ermakova S.P., Vishchuk O.S., Nazarenko E.L., Dmitrenok P.S., Zvyagintseva T.N. Anticancer activity in vitro of a fucoidan from the brown alga Fucus evanescens and its low-molecular fragments, structurally characterized by tandem mass-spectrometry. Carbohydr. Polym. 2012;87:186\u2013194. doi: 10.1016/j.carbpol.2011.07.036.", "ArticleIdList": ["10.1016/j.carbpol.2011.07.036", "34662949"]}, {"Citation": "Brohem C.A., Sawada T.C., Massaro R.R., Almeida R.L., Rivelli D.P., Ropke C.D., da Silva V.V., de Lima T.M., Curi R., Barros S.B., et al. Apoptosis induction by 4-nerolidylcatechol in melanoma cell lines. Toxicol. Vitr. 2009;23:111\u2013119. doi: 10.1016/j.tiv.2008.11.004.", "ArticleIdList": ["10.1016/j.tiv.2008.11.004", "19059332"]}, {"Citation": "Zhang W., Lan Y., Huang Q., Hua Z. Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK. Cytotechnology. 2013;65:447\u2013455. doi: 10.1007/s10616-012-9499-1.", "ArticleIdList": ["10.1007/s10616-012-9499-1", "PMC3597176", "23001390"]}, {"Citation": "Teh S.S., Ee G.C., Mah S.H., Yong Y.K., Lim Y.M., Rahmani M., Ahmad Z. In vitro cytotoxic, antioxidant, and antimicrobial activities of Mesua beccariana (Baill.) Kosterm., Mesua ferrea Linn., and Mesua congestiflora extracts. Biomed Res. Int. 2013;2013:517072. doi: 10.1155/2013/517072.", "ArticleIdList": ["10.1155/2013/517072", "PMC3780478", "24089682"]}, {"Citation": "Elmasri W.A., Hegazy M.-E.F., Mechref Y., Par\u00e9 P.W. Cytotoxic saponin poliusaposide from Teucrium polium. Rsc Adv. 2015;5:27126\u201327133. doi: 10.1039/C5RA02713F.", "ArticleIdList": ["10.1039/C5RA02713F"]}, {"Citation": "Nayak D., Pradhan S., Ashe S., Rauta P.R., Nayak B. Biologically synthesised silver nanoparticles from three diverse family of plant extracts and their anticancer activity against epidermoid A431 carcinoma. J. Colloid Interface Sci. 2015;457:329\u2013338. doi: 10.1016/j.jcis.2015.07.012.", "ArticleIdList": ["10.1016/j.jcis.2015.07.012", "26196716"]}, {"Citation": "Kuppusamy P., Yusoff M.M., Maniam G.P., Govindan N. A case study\u2013Regulation and functional mechanisms of cancer cells and control its activity using plants and their derivatives. J. Pharm. Res. 2013;6:884\u2013892. doi: 10.1016/j.jopr.2013.08.002.", "ArticleIdList": ["10.1016/j.jopr.2013.08.002"]}, {"Citation": "Balasubramanian R., Narayanan M., Kedalgovindaram L., Devarakonda Rama K. Cytotoxic activity of flavone glycoside from the stem of Indigofera aspalathoides Vahl. J. Nat. Med. 2006;61:80\u201383. doi: 10.1007/s11418-006-0026-6.", "ArticleIdList": ["10.1007/s11418-006-0026-6"]}, {"Citation": "Tourino S., Selga A., Jimenez A., Julia L., Lozano C., Lizarraga D., Cascante M., Torres J.L. Procyanidin fractions from pine (Pinus pinaster) bark: Radical scavenging power in solution, antioxidant activity in emulsion, and antiproliferative effect in melanoma cells. J. Agric. Food Chem. 2005;53:4728\u20134735. doi: 10.1021/jf050262q.", "ArticleIdList": ["10.1021/jf050262q", "15941307"]}, {"Citation": "Tran Q.L., Tezuka Y., Banskota A.H., Tran Q.K., Saiki I., Kadota S. New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity. J. Nat. Prod. 2001;64:1127\u20131132. doi: 10.1021/np0100385.", "ArticleIdList": ["10.1021/np0100385", "11575942"]}, {"Citation": "Lee M.H., Huang Z., Kim D.J., Kim S.H., Kim M.O., Lee S.Y., Xie H., Park S.J., Kim J.Y., Kundu J.K., et al. Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth. Cancer Prev. Res. 2013;6:455\u2013465. doi: 10.1158/1940-6207.CAPR-12-0425.", "ArticleIdList": ["10.1158/1940-6207.CAPR-12-0425", "PMC3644346", "23447564"]}, {"Citation": "Ramasamy K., Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008;269:352\u2013362. doi: 10.1016/j.canlet.2008.03.053.", "ArticleIdList": ["10.1016/j.canlet.2008.03.053", "PMC2612997", "18472213"]}, {"Citation": "Das S., Das J., Paul A., Samadder A., Khuda-Bukhsh A.R. Apigenin, a bioactive flavonoid from Lycopodium clavatum, stimulates nucleotide excision repair genes to protect skin keratinocytes from ultraviolet B-induced reactive oxygen species and DNA damage. J. Acupunct. Meridian Stud. 2013;6:252\u2013262. doi: 10.1016/j.jams.2013.07.002.", "ArticleIdList": ["10.1016/j.jams.2013.07.002", "24139463"]}, {"Citation": "Loizzo M.R., Tundis R., Menichini F., Saab A.M., Statti G.A., Menichini F. Cytotoxic activity of essential oils from labiatae and lauraceae families against in vitro human tumor models. Anticancer Res. 2007;27:3293\u20133299.", "ArticleIdList": ["17970073"]}, {"Citation": "Fouche G., Cragg G.M., Pillay P., Kolesnikova N., Maharaj V.J., Senabe J. In vitro anticancer screening of South African plants. J. Ethnopharmacol. 2008;119:455\u2013461. doi: 10.1016/j.jep.2008.07.005.", "ArticleIdList": ["10.1016/j.jep.2008.07.005", "18678239"]}, {"Citation": "Darmanin S., Wismayer P.S., Camilleri Podesta M.T., Micallef M.J., Buhagiar J.A. An extract from Ricinus communis L. leaves possesses cytotoxic properties and induces apoptosis in SK-MEL-28 human melanoma cells. Nat. Prod. Res. 2009;23:561\u2013571. doi: 10.1080/14786410802228579.", "ArticleIdList": ["10.1080/14786410802228579", "19384733"]}, {"Citation": "Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24:2783\u20132840.", "ArticleIdList": ["15517885"]}, {"Citation": "Niles R.M., McFarland M., Weimer M.B., Redkar A., Fu Y.M., Meadows G.G. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett. 2003;190:157\u2013163. doi: 10.1016/S0304-3835(02)00676-6.", "ArticleIdList": ["10.1016/S0304-3835(02)00676-6", "12565170"]}, {"Citation": "World Cancer Research Fund International.  [(accessed on 31 December 2018)]; Available online:  https://Www.Wcrf.Org/"}, {"Citation": "Globocan . Worldwide Incidence and Mortality of Cancer, 2002 [computer program]. Version 2.0. IARC CancerBase; Lyon, France: 2002."}, {"Citation": "Bezerra D.P., Marinho Filho J.D., Alves A.P., Pessoa C., de Moraes M.O., Pessoa O.D., Torres M.C., Silveira E.R., Viana F.A., Costa-Lotufo L.V. Antitumor activity of the essential oil from the leaves of Croton regelianus and its component ascaridole. Chem. Biodivers. 2009;6:1224\u20131231. doi: 10.1002/cbdv.200800253.", "ArticleIdList": ["10.1002/cbdv.200800253", "19697341"]}, {"Citation": "el-Sawi S.A., Motawae H.M., Ali A.M. Chemical composition, cytotoxic activity and antimicrobial activity of essential oils of leaves and berries of Juniperus phoenicea L. grown in Egypt. Afr. J. Tradit. Complement. Altern. Med. 2007;4:417\u2013426. doi: 10.4314/ajtcam.v4i4.31236.", "ArticleIdList": ["10.4314/ajtcam.v4i4.31236", "PMC2816504", "20161910"]}, {"Citation": "Scheck A.C., Perry K., Hank N.C., Clark W.D. Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells. BMC Complement. Altern. Med. 2006;6:27. doi: 10.1186/1472-6882-6-27.", "ArticleIdList": ["10.1186/1472-6882-6-27", "PMC1560162", "16914050"]}, {"Citation": "Tsai N.M., Lin S.Z., Lee C.C., Chen S.P., Su H.C., Chang W.L., Harn H.J. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo. Clin. Cancer Res. 2005;11:3475\u20133484. doi: 10.1158/1078-0432.CCR-04-1827.", "ArticleIdList": ["10.1158/1078-0432.CCR-04-1827", "15867250"]}, {"Citation": "Okokon J.E., Dar A., Choudhary M.I. Immunomodulatory, cytotoxic and antileishmanial activity of phytoconstituents of Croton zambesicus. Phytopharm. J. 2013;4:31\u201340."}, {"Citation": "Wu X.S., Xie T., Lin J., Fan H.Z., Huang-Fu H.J., Ni L.F., Yan H.F. An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. J. Pharm. Pharmacol. 2009;61:1653\u20131656. doi: 10.1211/jpp.61.12.0010.", "ArticleIdList": ["10.1211/jpp.61.12.0010", "19958588"]}, {"Citation": "Ferriola P.C., Cody V., Middleton E., Jr. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharm. 1989;38:1617\u20131624. doi: 10.1016/0006-2952(89)90309-2.", "ArticleIdList": ["10.1016/0006-2952(89)90309-2", "2730676"]}, {"Citation": "Dimitric Markovic J.M., Pejin B., Milenkovic D., Amic D., Begovic N., Mojovic M., Markovic Z.S. Antiradical activity of delphinidin, pelargonidin and malvin towards hydroxyl and nitric oxide radicals: The energy requirements calculations as a prediction of the possible antiradical mechanisms. Food Chem. 2017;218:440\u2013446. doi: 10.1016/j.foodchem.2016.09.106.", "ArticleIdList": ["10.1016/j.foodchem.2016.09.106", "27719933"]}, {"Citation": "Puli S., Jain A., Lai J.C., Bhushan A. Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells. Neurochem. Res. 2010;35:986\u2013993. doi: 10.1007/s11064-010-0142-2.", "ArticleIdList": ["10.1007/s11064-010-0142-2", "20177775"]}, {"Citation": "Tsai N.M., Chen Y.L., Lee C.C., Lin P.C., Cheng Y.L., Chang W.L., Lin S.Z., Harn H.J. The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo. J. Neurochem. 2006;99:1251\u20131262. doi: 10.1111/j.1471-4159.2006.04151.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.04151.x", "PMC1804119", "16987298"]}, {"Citation": "Jeon H.Y., Park C.G., Ham S.W., Choi S.H., Lee S.Y., Kim J.Y., Seo S., Jin X., Kim J.K., Eun K., et al. BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence. J. Med. Food. 2017;20:838\u2013845. doi: 10.1089/jmf.2017.3929.", "ArticleIdList": ["10.1089/jmf.2017.3929", "28792781"]}, {"Citation": "Das A., Banik N.L., Ray S.K. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells. Brain Res. 2008;1227:207\u2013215. doi: 10.1016/j.brainres.2008.06.045.", "ArticleIdList": ["10.1016/j.brainres.2008.06.045", "PMC2586291", "18602901"]}, {"Citation": "Zhang Y., Wang S.X., Ma J.W., Li H.Y., Ye J.C., Xie S.M., Du B., Zhong X.Y. EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition. J. Neuro-Oncol. 2015;121:41\u201352. doi: 10.1007/s11060-014-1604-1.", "ArticleIdList": ["10.1007/s11060-014-1604-1", "25173233"]}, {"Citation": "Galanti G., Fisher T., Kventsel I., Shoham J., Gallily R., Mechoulam R., Lavie G., Amariglio N., Rechavi G., Toren A. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncol. 2008;47:1062\u20131070. doi: 10.1080/02841860701678787.", "ArticleIdList": ["10.1080/02841860701678787", "17934890"]}, {"Citation": "Marcu J.P., Christian R.T., Lau D., Zielinski A.J., Horowitz M.P., Lee J., Pakdel A., Allison J., Limbad C., Moore D.H., et al. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol. Cancer Ther. 2010;9:180\u2013189. doi: 10.1158/1535-7163.MCT-09-0407.", "ArticleIdList": ["10.1158/1535-7163.MCT-09-0407", "PMC2806496", "20053780"]}, {"Citation": "Liao C.H., Pan S.L., Guh J.H., Chang Y.L., Pai H.C., Lin C.H., Teng C.M. Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis. 2005;26:968\u2013975. doi: 10.1093/carcin/bgi041.", "ArticleIdList": ["10.1093/carcin/bgi041", "15705600"]}, {"Citation": "Kim S., Lee T.J., Leem J., Choi K.S., Park J.W., Kwon T.K. Sanguinarine-induced apoptosis: Generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J. Cell. Biochem. 2008;104:895\u2013907. doi: 10.1002/jcb.21672.", "ArticleIdList": ["10.1002/jcb.21672", "18189268"]}, {"Citation": "Gautam N., Mantha A.K., Mittal S. Essential oils and their constituents as anticancer agents: A mechanistic view. Biomed Res. Int. 2014;2014:154106. doi: 10.1155/2014/154106.", "ArticleIdList": ["10.1155/2014/154106", "PMC4070586", "25003106"]}, {"Citation": "Li H., Tan G., Jiang X., Qiao H., Pan S., Jiang H., Kanwar J.R., Sun X. Therapeutic effects of matrine on primary and metastatic breast cancer. Am. J. Chin. Med. 2010;38:1115\u20131130. doi: 10.1142/S0192415X10008512.", "ArticleIdList": ["10.1142/S0192415X10008512", "21061465"]}, {"Citation": "Lai L.H., Fu Q.H., Liu Y., Jiang K., Guo Q.M., Chen Q.Y., Yan B., Wang Q.Q., Shen J.G. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol. Sin. 2012;33:523\u2013530. doi: 10.1038/aps.2011.209.", "ArticleIdList": ["10.1038/aps.2011.209", "PMC4003369", "22388073"]}, {"Citation": "Zu Y., Yu H., Liang L., Fu Y., Efferth T., Liu X., Wu N. Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells. Molecules. 2010;15:3200\u20133210. doi: 10.3390/molecules15053200.", "ArticleIdList": ["10.3390/molecules15053200", "PMC6263286", "20657472"]}, {"Citation": "Suhail M.M., Wu W., Cao A., Mondalek F.G., Fung K.M., Shih P.T., Fang Y.T., Woolley C., Young G., Lin H.K. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complement. Altern. Med. 2011;11:129. doi: 10.1186/1472-6882-11-129.", "ArticleIdList": ["10.1186/1472-6882-11-129", "PMC3258268", "22171782"]}, {"Citation": "Fawzy G.A., Al Ati H.Y., El Gamal A.A. Chemical composition and biological evaluation of essential oils of Pulicaria jaubertii. Pharmacogn. Mag. 2013;9:28\u201332. doi: 10.4103/0973-1296.108133.", "ArticleIdList": ["10.4103/0973-1296.108133", "PMC3647390", "23661990"]}, {"Citation": "Owolabi M.S., Ogundajo A.L., Dosoky N.S., Setzer W.N. The cytotoxic activity of Annona muricata leaf oil from Badagary, Nigeria. AJEONP. 2013;1:1\u201313."}, {"Citation": "Afoulous S., Ferhout H., Raoelison E.G., Valentin A., Moukarzel B., Couderc F., Bouajila J. Chemical composition and anticancer, antiinflammatory, antioxidant and antimalarial activities of leaves essential oil of Cedrelopsis grevei. Food Chem. Toxicol. 2013;56:352\u2013362. doi: 10.1016/j.fct.2013.02.008.", "ArticleIdList": ["10.1016/j.fct.2013.02.008", "23459148"]}, {"Citation": "Shahabipour S., Firuzi O., Asadollahi M., Miri M., Javidnia K. Essential Oil Composition and Cytotoxic Activity of Libanotis transcaucasica Schischk. from Iran. Nat. Prod. Chem. Res. 2013;1:1\u20133. doi: 10.4172/2329-6836.1000108.", "ArticleIdList": ["10.4172/2329-6836.1000108"]}, {"Citation": "Sharopov F.S., Wink M., Khalifaev D.R., Zhang H., Dosoky N.S., Setzer W.N. Composition and bioactivity of the essential oil of Melissa officinalis L. growing wild in Tajikistan. Int. J. Tradit. Nat. Med. 2013;2:86\u201396."}, {"Citation": "El Hadri A., del Rio M.G., Sanz J., Coloma A.G., Idaomar M., Ozonas B.R., Gonz\u00e1lez J.B., Reus M.I.S. Cytotoxic activity of \u03b1-humulene and transcaryophyllene from Salvia officinalis in animal and human tumor cells. R. Acad. Nac. Farm. 2010;76:343\u2013356."}, {"Citation": "Chen Y., Zhou C., Ge Z., Liu Y., Liu Y., Feng W., Li S., Chen G., Wei T. Composition and potential anticancer activities of essential oils obtained from myrrh and frankincense. Oncol. Lett. 2013;6:1140\u20131146. doi: 10.3892/ol.2013.1520.", "ArticleIdList": ["10.3892/ol.2013.1520", "PMC3796379", "24137478"]}, {"Citation": "Hussain A.I., Anwar F., Chatha S.A.S., Latif S., Sherazi S.T.H., Ahmad A., Worthington J., Sarker S.D. Chemical composition and bioactivity studies of the essential oils from two Thymus species from the Pakistani flora. Lwt Food Sci. Technol. 2013;50:185\u2013192. doi: 10.1016/j.lwt.2012.06.003.", "ArticleIdList": ["10.1016/j.lwt.2012.06.003"]}, {"Citation": "da Silva E.B., Matsuo A.L., Figueiredo C.R., Chaves M.H., Sartorelli P., Lago J.H. Chemical constituents and cytotoxic evaluation of essential oils from leaves of Porcelia macrocarpa (Annonaceae) Nat. Prod. Commun. 2013;8:277\u2013279. doi: 10.1177/1934578X1300800237.", "ArticleIdList": ["10.1177/1934578X1300800237", "23513748"]}, {"Citation": "Arunasree K.M. Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine. 2010;17:581\u2013588. doi: 10.1016/j.phymed.2009.12.008.", "ArticleIdList": ["10.1016/j.phymed.2009.12.008", "20096548"]}, {"Citation": "Chaouki W., Leger D.Y., Liagre B., Beneytout J.L., Hmamouchi M. Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells. Fundam. Clin. Pharmacol. 2009;23:549\u2013556. doi: 10.1111/j.1472-8206.2009.00738.x.", "ArticleIdList": ["10.1111/j.1472-8206.2009.00738.x", "19656204"]}, {"Citation": "Santha S., Bommareddy A., Rule B., Guillermo R., Kaushik R.S., Young A., Dwivedi C. Antineoplastic effects of alpha-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis. PLoS ONE. 2013;8:e56982. doi: 10.1371/annotation/c732480c-eb97-4eff-acb6-300797f4efa9.", "ArticleIdList": ["10.1371/annotation/c732480c-eb97-4eff-acb6-300797f4efa9", "PMC3579946", "23451128"]}, {"Citation": "Patel P.B., Thakkar V.R., Patel J.S. Cellular effect of curcumin and citral combination on breast cancer cells: Induction of apoptosis and cell cycle arrest. J. Breast Cancer. 2015;18:225\u2013234. doi: 10.4048/jbc.2015.18.3.225.", "ArticleIdList": ["10.4048/jbc.2015.18.3.225", "PMC4600686", "26472972"]}, {"Citation": "Gabrielli B., Brooks K., Pavey S. Defective cell cycle checkpoints as targets for anti-cancer therapies. Front. Pharmacol. 2012;3:9. doi: 10.3389/fphar.2012.00009.", "ArticleIdList": ["10.3389/fphar.2012.00009", "PMC3270485", "22347187"]}, {"Citation": "Hussain A.I., Anwar F., Chatha S.A., Jabbar A., Mahboob S., Nigam P.S. Rosmarinus officinalis essential oil: Antiproliferative, antioxidant and antibacterial activities. Braz. J. Microbiol. 2010;41:1070\u20131078. doi: 10.1590/S1517-83822010000400027.", "ArticleIdList": ["10.1590/S1517-83822010000400027", "PMC3769777", "24031588"]}, {"Citation": "Li Y.L., Yeung C.M., Chiu L.C., Cen Y.Z., Ooi V.E. Chemical composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Schefflera heptaphylla. Phytother. Res. 2009;23:140\u2013142. doi: 10.1002/ptr.2567.", "ArticleIdList": ["10.1002/ptr.2567", "18814213"]}, {"Citation": "Ashour H.M. Antibacterial, antifungal, and anticancer activities of volatile oils and extracts from stems, leaves, and flowers of Eucalyptus sideroxylon and Eucalyptus torquata. Cancer Biol. Ther. 2008;7:399\u2013403. doi: 10.4161/cbt.7.3.5367.", "ArticleIdList": ["10.4161/cbt.7.3.5367", "18075306"]}, {"Citation": "Sireesha D., Reddy B.S., Reginald B.A., Samatha M., Kamal F. Effect of amygdalin on oral cancer cell line: An in vitro study. J. Oral Maxillofac. Pathol. 2019;23:104\u2013107. doi: 10.4103/jomfp.JOMFP_281_18.", "ArticleIdList": ["10.4103/jomfp.JOMFP_281_18", "PMC6503803", "31110425"]}, {"Citation": "Jo J.R., Park J.S., Park Y.K., Chae Y.Z., Lee G.H., Park G.Y., Jang B.C. Pinus densiflora leaf essential oil induces apoptosis via ROS generation and activation of caspases in YD-8 human oral cancer cells. Int. J. Oncol. 2012;40:1238\u20131245. doi: 10.3892/ijo.2011.1263.", "ArticleIdList": ["10.3892/ijo.2011.1263", "PMC3584576", "22086183"]}, {"Citation": "Chang W.L., Cheng F.C., Wang S.P., Chou S.T., Shih Y. Cinnamomum cassia essential oil and its major constituent cinnamaldehyde induced cell cycle arrest and apoptosis in human oral squamous cell carcinoma HSC-3 cells. Environ. Toxicol. 2017;32:456\u2013468. doi: 10.1002/tox.22250.", "ArticleIdList": ["10.1002/tox.22250", "26919256"]}, {"Citation": "Cha J.D., Kim J.Y. Essential oil from Cryptomeria japonica induces apoptosis in human oral epidermoid carcinoma cells via mitochondrial stress and activation of caspases. Molecules. 2012;17:3890\u20133901. doi: 10.3390/molecules17043890.", "ArticleIdList": ["10.3390/molecules17043890", "PMC6268749", "22466850"]}, {"Citation": "Saleh A.I., Mohamed I., Mohamed A.A., Abdelkader M., Yalcin H.C., Aboulkassim T., Batist G., Yasmeen A., Moustafa A.A. Elaeagnus angustifolia Plant Extract Inhibits Angiogenesis and Downgrades Cell Invasion of Human Oral Cancer Cells via Erk1/Erk2 Inactivation. Nutr. Cancer. 2018;70:297\u2013305. doi: 10.1080/01635581.2018.1412472.", "ArticleIdList": ["10.1080/01635581.2018.1412472", "29300111"]}, {"Citation": "Su Y.C., Hsu K.P., Wang E.I., Ho C.L. Composition and in vitro anticancer activities of the leaf essential oil of Neolitsea variabillima from Taiwan. Nat. Prod. Commun. 2013;8:531\u2013532. doi: 10.1177/1934578X1300800432.", "ArticleIdList": ["10.1177/1934578X1300800432", "23738472"]}, {"Citation": "Li S., Cha I.H., Nam W. Chios mastic gum extracts as a potent antitumor agent that inhibits growth and induces apoptosis of oral cancer cells. Asian Pac. J. Cancer Prev. 2011;12:1877\u20131880.", "ArticleIdList": ["22126583"]}, {"Citation": "Moon S.M., Yun S.J., Kook J.K., Kim H.J., Choi M.S., Park B.R., Kim S.G., Kim B.O., Lee S.Y., Ahn H., et al. Anticancer activity of Saussurea lappa extract by apoptotic pathway in KB human oral cancer cells. Pharm. Biol. 2013;51:1372\u20131377. doi: 10.3109/13880209.2013.792847.", "ArticleIdList": ["10.3109/13880209.2013.792847", "23855888"]}, {"Citation": "Fekrazad R., Afzali M., Pasban-Aliabadi H., Esmaeili-Mahani S., Aminizadeh M., Mostafavi A. Cytotoxic Effect of Thymus caramanicus Jalas on Human Oral Epidermoid Carcinoma KB Cells. Braz. Dent. J. 2017;28:72\u201377. doi: 10.1590/0103-6440201700737.", "ArticleIdList": ["10.1590/0103-6440201700737", "28301021"]}, {"Citation": "Nedel F., Begnini K., Carvalho P.H., Lund R.G., Beira F.T., Del Pino F.A. Antiproliferative activity of flower hexane extract obtained from Mentha spicata associated with Mentha rotundifolia against the MCF7, KB, and NIH/3T3 cell lines. J. Med. Food. 2012;15:955\u2013958. doi: 10.1089/jmf.2011.0340.", "ArticleIdList": ["10.1089/jmf.2011.0340", "23066647"]}, {"Citation": "Fathilah A.R., Sujata R., Norhanom A.W., Adenan M.I. Antiproliferative activity of aqueous extract of Piper betle L. and Psidium guajava L. on KB and HeLa cell lines. J. Med. Plants Res. 2010;4:987\u2013990."}, {"Citation": "Kim L.-H., Khadka S., Shin J.-A., Jung J.-Y., Ryu M.-H., Yu H.-J., Lee H.N., Jang B., Yang I.-H., Won D.-H., et al. Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3. Oncotarget. 2017;8:91306\u201391315. doi: 10.18632/oncotarget.20444.", "ArticleIdList": ["10.18632/oncotarget.20444", "PMC5710925", "29207645"]}, {"Citation": "Cheng C., Dong W. Aloe-Emodin Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Colorectal Cancer Cells. Med. Sci. Monit. 2018;24:6331\u20136339. doi: 10.12659/MSM.908400.", "ArticleIdList": ["10.12659/MSM.908400", "PMC6142869", "30199885"]}, {"Citation": "Pejin B., Iodice C., Bogdanovi\u0107 G., Koji\u0107 V., Te\u0161evi\u0107 V. Stictic acid inhibits cell growth of human colon adenocarcinoma HT-29 cells. Arab. J. Chem. 2017;10:S1240\u2013S1242. doi: 10.1016/j.arabjc.2013.03.003.", "ArticleIdList": ["10.1016/j.arabjc.2013.03.003"]}, {"Citation": "Carnesecchi S., Bras-Goncalves R., Bradaia A., Zeisel M., Gosse F., Poupon M.F., Raul F. Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts. Cancer Lett. 2004;215:53\u201359. doi: 10.1016/j.canlet.2004.06.019.", "ArticleIdList": ["10.1016/j.canlet.2004.06.019", "15374632"]}, {"Citation": "Okada T., Sawada T., Osawa T., Adachi M., Kubota K. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World J. Gastroenterol. 2008;14:1378\u20131382. doi: 10.3748/wjg.14.1378.", "ArticleIdList": ["10.3748/wjg.14.1378", "PMC2693685", "18322951"]}, {"Citation": "Melstrom L.G., Salabat M.R., Ding X.Z., Milam B.M., Strouch M., Pelling J.C., Bentrem D.J. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells. Pancreas. 2008;37:426\u2013431. doi: 10.1097/MPA.0b013e3181735ccb.", "ArticleIdList": ["10.1097/MPA.0b013e3181735ccb", "18953257"]}, {"Citation": "Wicker C.A., Sahu R.P., Kulkarni-Datar K., Srivastava S.K., Brown T.L. BITC Sensitizes Pancreatic Adenocarcinomas to TRAIL-induced Apoptosis. Cancer Growth Metastasis. 2010;2009:45\u201355. doi: 10.4137/CGM.S3982.", "ArticleIdList": ["10.4137/CGM.S3982", "PMC2886296", "20559452"]}, {"Citation": "Bence A.K., Adams V.R., Crooks P.A. L-Canavanine as a radiosensitization agent for human pancreatic cancer cells. Mol. Cell. Biochem. 2003;244:37\u201343. doi: 10.1023/A:1022435202066.", "ArticleIdList": ["10.1023/A:1022435202066", "12701807"]}, {"Citation": "Lee S.H., Ryu J.K., Lee K.Y., Woo S.M., Park J.K., Yoo J.W., Kim Y.T., Yoon Y.B. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett. 2008;259:39\u201349. doi: 10.1016/j.canlet.2007.09.015.", "ArticleIdList": ["10.1016/j.canlet.2007.09.015", "17967505"]}, {"Citation": "Li Z., Zhang Y., Chen L., Li H. The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2. Food Funct. 2018;9:3018\u20133027. doi: 10.1039/C8FO00033F.", "ArticleIdList": ["10.1039/C8FO00033F", "29770817"]}, {"Citation": "Jia S., Xu X., Zhou S., Chen Y., Ding G., Cao L. Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways. Cell Death Dis. 2019;10:142. doi: 10.1038/s41419-019-1366-y.", "ArticleIdList": ["10.1038/s41419-019-1366-y", "PMC6374379", "30760707"]}, {"Citation": "Hoca M., Becer E., Kabadayi H., Yucecan S., Vatansever H.S. The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell. Nutr. Cancer. 2019:1\u201312. doi: 10.1080/01635581.2019.1670853.", "ArticleIdList": ["10.1080/01635581.2019.1670853", "31595775"]}, {"Citation": "Tourino S., Lizarraga D., Carreras A., Lorenzo S., Ugartondo V., Mitjans M., Vinardell M.P., Julia L., Cascante M., Torres J.L. Highly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: Electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells. Chem. Res. Toxicol. 2008;21:696\u2013704. doi: 10.1021/tx700425n.", "ArticleIdList": ["10.1021/tx700425n", "18311930"]}, {"Citation": "Cowan J., Shadab M., Nadkarni D.H., Kc K., Velu S.E. A novel marine natural product derived pyrroloiminoquinone with potent activity against skin cancer cells. Mar. drugs. 2019;17:443. doi: 10.3390/md17080443.", "ArticleIdList": ["10.3390/md17080443", "PMC6722685", "31357586"]}, {"Citation": "Kremer J.L., Melo G.P., Marinello P.C., Bordini H.P., Rossaneis A.C., Sabio L.R., Cecchini R., Cecchini A.L., Verri W.A., Jr., Luiz R.C. Citral prevents UVB-induced skin carcinogenesis in hairless mice. J. Photochem. Photobiol. B Biol. 2019;198:111565. doi: 10.1016/j.jphotobiol.2019.111565.", "ArticleIdList": ["10.1016/j.jphotobiol.2019.111565", "31374350"]}, {"Citation": "Arcella A., Oliva M.A., Sanchez M., Staffieri S., Esposito V., Giangaspero F., Cantore G. Effects of hispolon on glioblastoma cell growth. Environ. Toxicol. 2017;32:2113\u20132123. doi: 10.1002/tox.22419.", "ArticleIdList": ["10.1002/tox.22419", "28618133"]}, {"Citation": "Arcella A., Oliva M.A., Staffieri S., Sanchez M., Madonna M., Riozzi B., Esposito V., Giangaspero F., Frati L. Effects of aloe emodin on U87MG glioblastoma cell growth: In vitro and in vivo study. Environ. Toxicol. 2018;33:1160\u20131167. doi: 10.1002/tox.22622.", "ArticleIdList": ["10.1002/tox.22622", "30218594"]}, {"Citation": "Jin J., Qiu S., Wang P., Liang X., Huang F., Wu H., Zhang B., Zhang W., Tian X., Xu R., et al. Cardamonin inhibits breast cancer growth by repressing HIF-1alpha-dependent metabolic reprogramming. J. Exp. Clin. Cancer Res. 2019;38:377. doi: 10.1186/s13046-019-1351-4.", "ArticleIdList": ["10.1186/s13046-019-1351-4", "PMC6712736", "31455352"]}, {"Citation": "Zhang J., Zheng Z., Wu M., Zhang L., Wang J., Fu W., Xu N., Zhao Z., Lao Y., Xu H. The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2. Cell Death Dis. 2019;10:554. doi: 10.1038/s41419-019-1789-5.", "ArticleIdList": ["10.1038/s41419-019-1789-5", "PMC6639345", "31320607"]}, {"Citation": "Periasamy V.S., Athinarayanan J., Alshatwi A.A. Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells. Ultrason. Sonochem. 2016;31:449\u2013455. doi: 10.1016/j.ultsonch.2016.01.035.", "ArticleIdList": ["10.1016/j.ultsonch.2016.01.035", "26964971"]}, {"Citation": "Stone S.C., Vasconcellos F.A., Lenard\u00e3o E.J., do Amaral R.C., Jacob R.G., Leite F.L. Evaluation of potential use of Cymbopogon sp. essential oils,(R)-citronellal and N-citronellylamine in cancer chemotherapy. Int. J. Appl. Res. Nat. Prod. 2013;6:11\u201315."}, {"Citation": "Yu J.Q., Lei J.C., Zhang X.Q., Yu H.D., Tian D.Z., Liao Z.X., Zou G.L. Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel. Food Chem. 2011;126:1593\u20131598. doi: 10.1016/j.foodchem.2010.12.027.", "ArticleIdList": ["10.1016/j.foodchem.2010.12.027", "25213932"]}, {"Citation": "Dwivedi V., Shrivastava R., Hussain S., Ganguly C., Bharadwaj M. Comparative anticancer potential of clove (Syzygium aromaticum)\u2014An Indian spice\u2014Against cancer cell lines of various anatomical origin. Asian Pac. J. Cancer Prev. 2011;12:1989\u20131993.", "ArticleIdList": ["22292639"]}, {"Citation": "Al-Kalaldeh J.Z., Abu-Dahab R., Afifi F.U. Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells. Nutr. Res. 2010;30:271\u2013278. doi: 10.1016/j.nutres.2010.04.001.", "ArticleIdList": ["10.1016/j.nutres.2010.04.001", "20534330"]}, {"Citation": "Bendaoud H., Romdhane M., Souchard J.P., Cazaux S., Bouajila J. Chemical composition and anticancer and antioxidant activities of Schinus molle L. and Schinus terebinthifolius Raddi berries essential oils. J. Food Sci. 2010;75:C466\u2013C472. doi: 10.1111/j.1750-3841.2010.01711.x.", "ArticleIdList": ["10.1111/j.1750-3841.2010.01711.x", "20722898"]}, {"Citation": "Diaz C., Quesada S., Brenes O., Aguilar G., Ciccio J.F. Chemical composition of Schinus molle essential oil and its cytotoxic activity on tumour cell lines. Nat. Prod. Res. 2008;22:1521\u20131534. doi: 10.1080/14786410701848154.", "ArticleIdList": ["10.1080/14786410701848154", "19023816"]}, {"Citation": "Lei J., Yu J., Yu H., Liao Z. Composition, cytotoxicity and antimicrobial activity of essential oil from Dictamnus dasycarpus. Food Chem. 2008;107:1205\u20131209. doi: 10.1016/j.foodchem.2007.09.050.", "ArticleIdList": ["10.1016/j.foodchem.2007.09.050"]}, {"Citation": "Apel M.A., Lima M.E.L., Souza A., Cordeiro I., Young M.C.M., Sobral M.E., Suffredini I.B., Moreno P.R.H. Screening of the biological activity from essential oils of native species from the Atlantic rain forest (S\u00e3o Paulo\u2013Brazil) Pharmacologyonline. 2006;3:376\u2013383."}, {"Citation": "Monajemi R., Oryan S., Haeri-Roohani A., Ghannadi A., Jafarian A. Cytotoxic Effects of Essential Oils of Some Iranian Citrus Peels. Iran. J. Pharm. Res. 2010;4:183\u2013187. doi: 10.22037/ijpr.2010.635.", "ArticleIdList": ["10.22037/ijpr.2010.635"]}, {"Citation": "Goren A., Topcu G., Bilsel G., Bilsel M., Aydogmus Z., Pezzuto J.M. The chemical constituents and biological activity of essential oil of Lavandula stoechas ssp. stoechas. Z. Fur Nat. 2002;57:797\u2013800. doi: 10.1515/znc-2002-9-1007.", "ArticleIdList": ["10.1515/znc-2002-9-1007", "12440714"]}, {"Citation": "Manikandan P., Vinothini G., Vidya Priyadarsini R., Prathiba D., Nagini S. Eugenol inhibits cell proliferation via NF-kappaB suppression in a rat model of gastric carcinogenesis induced by MNNG. Investig. New Drugs. 2011;29:110\u2013117. doi: 10.1007/s10637-009-9345-2.", "ArticleIdList": ["10.1007/s10637-009-9345-2", "19851710"]}, {"Citation": "Sajjadi M., Karimi E. Galbanic acid: Induced antiproliferation in estrogen receptor-negative breast cancer cells and enhanced cellular redox state in the human dermal fibroblasts. J. Biochem. Mol. Toxicol. 2019:e22402. doi: 10.1002/jbt.22402.", "ArticleIdList": ["10.1002/jbt.22402", "31576639"]}, {"Citation": "Kakarala M., Brenner D.E., Korkaya H., Cheng C., Tazi K., Ginestier C., Liu S., Dontu G., Wicha M.S. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat. 2010;122:777\u2013785. doi: 10.1007/s10549-009-0612-x.", "ArticleIdList": ["10.1007/s10549-009-0612-x", "PMC3039120", "19898931"]}, {"Citation": "Pejin B., Kojic V., Bogdanovic G. An insight into the cytotoxic activity of phytol at in vitro conditions. Nat. Prod. Res. 2014;28:2053\u20132056. doi: 10.1080/14786419.2014.921686.", "ArticleIdList": ["10.1080/14786419.2014.921686", "24896297"]}, {"Citation": "Yu P., Liu Q., Liu K., Yagasaki K., Wu E., Zhang G. Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology. 2009;59:219\u2013229. doi: 10.1007/s10616-009-9225-9.", "ArticleIdList": ["10.1007/s10616-009-9225-9", "PMC2774574", "19760125"]}, {"Citation": "Choi Y.H., Choi W.Y., Hong S.H., Kim S.O., Kim G.Y., Lee W.H., Yoo Y.H. Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem.-Biol. Interact. 2009;179:185\u2013191. doi: 10.1016/j.cbi.2008.11.009.", "ArticleIdList": ["10.1016/j.cbi.2008.11.009", "19063874"]}, {"Citation": "Fu L.W., Zhang Y.M., Liang Y.J., Yang X.P., Pan Q.C. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur. J. Cancer. 2002;38:418\u2013426. doi: 10.1016/S0959-8049(01)00356-2.", "ArticleIdList": ["10.1016/S0959-8049(01)00356-2", "11818209"]}, {"Citation": "Li X., Xie W., Xie C., Huang C., Zhu J., Liang Z., Deng F., Zhu M., Zhu W., Wu R., et al. Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation. Phytother. Res. 2014;28:1553\u20131560. doi: 10.1002/ptr.5167.", "ArticleIdList": ["10.1002/ptr.5167", "24831732"]}, {"Citation": "Bimonte S., Barbieri A., Palma G., Rea D., Luciano A., D\u2019Aiuto M., Arra C., Izzo F. Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer. Biomed Res. Int. 2015;2015:878134. doi: 10.1155/2015/878134.", "ArticleIdList": ["10.1155/2015/878134", "PMC4386568", "25879038"]}, {"Citation": "Aggarwal B.B., Shishodia S., Takada Y., Banerjee S., Newman R.A., Bueso-Ramos C.E., Price J.E. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res. 2005;11:7490\u20137498. doi: 10.1158/1078-0432.CCR-05-1192.", "ArticleIdList": ["10.1158/1078-0432.CCR-05-1192", "16243823"]}, {"Citation": "Lv Z.D., Liu X.P., Zhao W.J., Dong Q., Li F.N., Wang H.B., Kong B. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int. J. Clin. Exp. Pathol. 2014;7:2818\u20132824.", "ArticleIdList": ["PMC4097278", "25031701"]}, {"Citation": "Khan H., Ullah H., Martorell M., Esteban Valdes S., Belwal T., Tejada S., Sureda A., Kamal M.A. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Semin. Cancer Biol. 2019 doi: 10.1016/j.semcancer.2019.07.023.", "ArticleIdList": ["10.1016/j.semcancer.2019.07.023", "31374244"]}, {"Citation": "Pezzani R., Salehi B., Vitalini S., Iriti M., Zuniga F.A., Sharifi-Rad J., Martorell M., Martins N. Synergistic effects of plant derivatives and conventional chemotherapeutic agents: An update on the cancer perspective. Medicina. 2019;55:110. doi: 10.3390/medicina55040110.", "ArticleIdList": ["10.3390/medicina55040110", "PMC6524059", "30999703"]}, {"Citation": "Mitra A.K., Agrahari V., Mandal A., Cholkar K., Natarajan C., Shah S., Joseph M., Trinh H.M., Vaishya R., Yang X., et al. Novel delivery approaches for cancer therapeutics. J. Control. Release. 2015;219:248\u2013268. doi: 10.1016/j.jconrel.2015.09.067.", "ArticleIdList": ["10.1016/j.jconrel.2015.09.067", "PMC4656058", "26456750"]}, {"Citation": "Kunnumakkara A.B., Bordoloi D., Sailo B.L., Roy N.K., Thakur K.K., Banik K., Shakibaei M., Gupta S.C., Aggarwal B.B. Cancer drug development: The missing links. Exp. Biol. Med. 2019;244:663\u2013689. doi: 10.1177/1535370219839163.", "ArticleIdList": ["10.1177/1535370219839163", "PMC6552400", "30961357"]}, {"Citation": "Hoonjan M., Jadhav V., Bhatt P. Arsenic trioxide: insights into its evolution to an anticancer agent. J. Biol. Inorg. Chem. 2018;23:313\u2013329. doi: 10.1007/s00775-018-1537-9.", "ArticleIdList": ["10.1007/s00775-018-1537-9", "29396610"]}, {"Citation": "Slezakova S., Ruda-Kucerova J. Anticancer activity of artemisinin and its derivatives. Anticancer Res. 2017;37:5995\u20136003. doi: 10.21873/anticanres.12046.", "ArticleIdList": ["10.21873/anticanres.12046", "29061778"]}, {"Citation": "Dai X., Zhang J., Arfuso F., Chinnathambi A., Zayed M.E., Alharbi S.A., Kumar A.P., Ahn K.S., Sethi G. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy. Exp. Biol. Med. 2015;240:760\u2013773. doi: 10.1177/1535370215579167.", "ArticleIdList": ["10.1177/1535370215579167", "PMC4935211", "25854879"]}]}], "History": [{"Year": "2019", "Month": "10", "Day": "9"}, {"Year": "2019", "Month": "10", "Day": "26"}, {"Year": "2019", "Month": "10", "Day": "27"}, {"Year": "2019", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31683894", "PMC6920853", "10.3390/biom9110679", "biom9110679"]}}]}